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Mycobacterium tuberculosis (Mtb) as a causative agent of human 
tuberculosis has successfully adapted to survive within the host for decades, 
and the bacterium’s ability to metabolize host-derived lipids (fatty acids and 
cholesterol) is thought to enable this persistence. Here we provide insights into 
previously unknown regulatory mechanisms of lipid assimilation in Mtb. 
Specifically, we identified a fatty acid transporter Mce1. We determined 
that previously uncharacterized protein Rv3723/LucA coordinates uptake of 
both fatty acids and cholesterol through its interaction with accessory subunits 
of Mce1 and Mce4, respectively. Rv3723/LucA or Mce accessory subunits 
provide stability to the lipid transporters by protecting from degradation with 
protease. Moreover, cholesterol and fatty acids imported into the cell send 
downstream signals to modulate assimilation of each other. Our results 
demonstrate that fatty acid and cholesterol import in Mtb is exquisitely 
coordinated through a network of proteins associated with Mce1 and Mce4. 
Additionally, to further define genes required for assimilation of fatty 
acids during macrophage infection, we employed an unbiased approach of 
genetic screen using metabolic labeling. We identified a number of genes with 
previously unknown link to lipid metabolism, and also determined that Mce1, 
Mce accessory protein OmamB and the ATPase MceG are required for import 
of fatty acids by Mtb inside the host. 
Elucidation of the mechanisms for lipid uptake in Mtb will help us 
understand key survival strategies of the pathogen, and identify new points of 
vulnerability for drug discovery. 
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Introduction 
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Mycobacterium tuberculosis pathogenesis 
Gram-positive Mycobacterium tuberculosis (Mtb), the causative agent 
of tuberculosis (TB), is the number one killer among pathogens, with over 1.5 
million deaths every year (WHO, 2016). TB infection is initiated after Mtb is 
inhaled as aerosol droplets and is engulfed by resident lung phagocytes, 
prevalently by alveolar macrophages. These leukocytes are designed to 
degrade all the small foreign objects that reach the lungs, but Mtb perturbs 
function of macrophages to transform them into a niche for the pathogen’s 
survival. Initial infection leads to infiltration of other immune cells, including 
neutrophils, monocytes and lymphocytes. As infection progresses, Th1 
lymphocytes produce IFN-γ to activate macrophages which causes more 
inflammation through production of TNF, while IL-10 production reduces 
inflammation. This balanced inflammation is believed to be the main 
contributor in formation and progression of granuloma (Mayer-Barber et al., 
2014; Gideon et al., 2015; Lin et al., 2016) – a cluster of cells that surround the 
infection site. This structure serves dual purpose: it contains the infection at 
the local level, but it also protects Mtb from elimination (Ramakrishnan, 2012). 
Infected individuals contain granulomas of differing states: from newly formed, 
healed, to cavitating (i.e. releasing Mtb for reinfection), and bacteria 
experience very distinct environments within these lesions (Flynn et al., 2015). 
The outcome of infection is determined at the level of individual granuloma 
(Lin et al., 2013), making treatment of disease extremely difficult (Via et al., 
2015).  
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Lipid diet of Mtb during infection 
With the complicated spectrum of niches that Mtb has to adapt to, it 
seems that the pathogen always secures availability of its preferred nutrient – 
lipids (Russell et al., 2010). Mtb infection causes induction of a foamy 
phenotype in macrophages (Almeida, et al., 2012; Singh et al., 2012), the 
hallmark of which is accumulation of lipid bodies most likely comprised of 
triacylglycerols and cholesterol esters. Mtb can acquire fatty acids directly from 
the macrophage (Lee et al., 2013) or as products of triacylglycerol breakdown 
(Daniel et al., 2011). Mycobacteria-containing vacuoles can be found fused 
with these lipid bodies as revealed by electron microscopy, suggesting lipid 
bodies as a possible route of fatty acid delivery to the pathogen (Peyron et al., 
2008; Podinovskaia, et al., 2013; Caire-Brändli et al., 2014). Foamy 
macrophages are abundant in Mtb granulomas (Hunter et al., 2007; Cáceres 
et al., 2009), and these lesions are comprised of cholesterol, cholesterol ester 
and triacylglycerols (Kim et al., 2010), providing an excellent source of 
nutrients to the pathogen. Importantly, Mtb isolated from the mouse lungs had 
higher preference for metabolism of fatty acids compared to bacteria grown in 
axenic culture, indicating metabolic shift towards fatty acids in Mtb in vivo 
(Segal & Bloch, 1956). 
Importance of lipid metabolism for Mtb is supported by strikingly high 
prevalence of lipid metabolism genes in its genome: ~250 compared to only 
50 in E. coli (Cole et al., 1998), with 100 devoted to beta-oxidation. Mtb is 
among few bacteria possessing full enzymatic machinery required for 
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cholesterol breakdown (Van der Geize et al., 2007; Chang et al., 2009) 
inherited from its saprophytic ancestors (Wipperman et al., 2014; Olive & 
Sassetti, 2016). These cholesterol catabolism pathways are part of 89 genes 
of KstR1 and KstR2 regulons that respond transcriptionally to cholesterol. 
Importantly, these cholesterol and fatty acid metabolism-related genes are 
upregulated by Mtb in macrophage, in murine model of infection and in the 
human lung tissue (Schnappinger et al., 2003; Rachman et al., 2006; Rohde 
et al., 2007; Fontán et al., 2008; Tailleux et al., 2008; Homolka et al., 2010; 
Rohde, et al., 2012). 
Both fatty acids and cholesterol are used by Mtb for energy production 
and for synthesis of essential lipids. Importance of cholesterol metabolism 
during infection was supported recently by identification of new 
antituberculosis compounds inhibiting cholesterol metabolism (VanderVen et 
al., 2015). Inactivation of isocitrate lyase that integrates cholesterol and fatty 
acids into central carbon metabolism results in a severe survival defect of the 
pathogen in mouse infection and in macrophages (McKinney et al., 2000; 
Muñoz-Elías & McKinney, 2005). Preferential utilization of fatty acids versus 
carbohydrates by Mtb during infection is supported by the pathogen’s 
dependency on the gluconeogenic pathway (Marrero et al., 2010). Synthesis 
of important virulence factors of Mtb, such as phthiocerol dimycocerosates 
(PDIM) and sulfolipid-1, is dependent on both fatty acids and cholesterol 
(Rainwater & Kolattukudy, 1982; Cox et al., 1999; Jain et al., 2007; Kaur et al., 
2009; Lee, et al., 2013). Additionally, excess of fatty acids can be esterified 
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and stored within Mtb in the form of triacylglycerol (TAG) (Daniel et al., 2011). 
Induction of TAG synthesis is also triggered by stress conditions suggesting 
that this pathway is used to reduce bacterial growth by diverting fatty acids 
from TCA cycle (Baek et al., 2011). 
Although significance of lipid metabolism for Mtb pathogenesis is 
undeniable, specific mechanisms of fatty acid and cholesterol acquisition are 
not well understood. We provide an overview of literature on this topic further 
on. 
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Known lipid transporters in bacteria 
Lipid metabolism in bacteria has been studied for decades, however, 
not that much is known about mechanisms of lipid transport. There was a long 
standing presumption that lipids can simply diffuse through the lipid bilayer of 
the cytosolic or outer membrane, but once the exquisite mechanisms of fatty 
acid metabolism regulation were described in gram-negative E. coli 
(overviewed in Fujita et al., 2007), it became obvious that import of fatty acids 
had to be transporter-mediated (Abumrad et al., 1998). Long-chain fatty acids 
are transported by E.coli in two-steps: outer membrane-associated protein 
FadL in the form of β-barrel binds and translocates the substrate by means of 
the lateral opening in the barrel wall from extracellular space into the outer 
membrane with subsequent diffusion into the periplasmic space, followed by 
transfer by cytosolic membrane protein acyl-CoA synthase, FadD, which feeds 
acyl CoA thioester to cytosolic enzymes for further metabolism (Black, 1991; 
Black et al., 1992; Lepore et al., 2011). This transport is dependent on 
intracellular ATP pools and on an energized inner membrane. Homologs of 
FadD exist in almost every animal kingdom, including one Rv1206/FadD6 in 
Mtb (Hirsch et al., 1998). This protein was found to function as acyl-CoA 
synthase with preference towards oleic acid to provide building blocks for 
triacylglycerol synthesis in Mtb, however no significant role in fatty acid uptake 
was determined (Daniel et al., 2014). Mtb does not have any proteins 
homologous to FadL. 
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Recently, the first cholesterol transport system was identified in another 
gram-negative bacterium Sterolibacterium denitrificans (Lin et al., 2015). 
Cholesterol and similar sterols are first transferred through the outer 
membrane by a FadL-like transport system. Then multiple modifications of the 
sterol molecule take place, products of which are then delivered into the 
cytosol for catabolism. Interestingly, this import is not ATP-dependent. 
Finally, gram-positive actinobacteria Mtb and Rhodococcus jostii were 
found to transport cholesterol through the ABC (ATP-binding cassette) 
transporter Mce4 (Mohn et al., 2008; Pandey & Sassetti, 2008). The rest of 
this review will focus on this type of transporter in Mtb. 
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Mtb Mce1-4 proteins are ABC transporters 
The genome of Mtb contains four homologous unlinked mce loci (mce1-
mce4). The name Mce stands for mammalian cell entry and was assigned 
based on the role of these proteins in invasion of nonphagocytic HeLa cells 
(Arruda et al., 1993; Chitale et al., 2001). These loci share homology to ABC 
(ATP binding cassette) transporters, where each mce locus consists of two 
yrbE genes, encoding ABC transporter permeases, six mce genes for 
substrate-binding proteins (SBPs), plus varying numbers of accessory mam 
genes (Mce associated membrane proteins or in old nomenclature mas – Mce 
associated proteins), encoding proteins of unknown function (Figure 1.1). 
Additionally, five proteins homologous to accessory Mam subunits were 
encoded by genes scattered throughout the Mtb genome (Perkowski et al., 
2016). These proteins were termed OmamA-E for orphaned Mce-associated 
membrane proteins. All ABC transporters require ATPase for their activity, and 
genetic epistasis studies predicted Rv0655/MceG to perform this function for 
all of the four Mce transporters in Mtb (Joshi et al., 2006). The rv0655/mceG is 
located separately from all of the mce1-4 loci in Mtb genome.  
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Figure 1.1. Organization of the mce1-4 loci in Mtb. Adapted from (Casali & 
Riley, 2007). 
 
Import through ABC transporters begins when a substrate binding 
protein (SBP) delivers the substrate to the two permease domains that span 
across the cytoplasmic membrane and are inward-facing in the idle position 
(Figure 1.2). ATPase dimers located in the cytosol always have ATP bound to 
them with negligible futile activity. The ATPase dimer begins ATP hydrolysis 
only when its two domains come in close contact with each other, exposing 
ATP to the active site of the enzyme. Because protrusions of the two 
permeases are physically inserted into ATPases, this closed position of two 
ATPases pushes permeases towards each other, which results in outward-
facing conformation of the transporter. Due to resulting physical constrains, 
SBP releases substrate that binds to a specific site formed by two permeases. 
When ATP hydrolysis is complete, two ATPase subunits dissociate from each 
other, pulling the permease subunits apart so that they release the substrate 
into the cytoplasm (Locher, 2016). 
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Figure 1.2. Mechanism of import for Type I ABC transporter. Step 1 – 
binding of a substrate by substrate-binding protein (SBP). Step 2 – Transfer of 
a substrate from the SBP to permease/transmembrane domains. Step 3. 
Release of the substrate in cytosol due to hydrolysis of ATP by 
ATPase/nucleotide binding domain. Nucleotide binding domains or ATPases 
(analogous to MceG of Mtb) are shown in magenta and purple, permeases 
(analogous to YrbEA and YrbEB) are in yellow and green, SBP – in brown, 
and substrate – in blue. Adapted from (Locher, 2016). 
 
  
11 
Transcriptional regulation of the mce loci 
The mce loci can be transcribed as a singular operon (spanning from 
yrbE genes all the way through accessory mam genes), or as smaller regions 
(Casali et al., 2006; Mohn et al., 2008). The mce1, mce3 and mce4 genes are 
expressed in bacilli isolated from the lungs of rabbits (Kumar et al., 2003). 
Interestingly, mce1-3 loci have transcriptional repressors mce1R-3R 
upstream, while mce4 locus is void of it (Figure 1.1). Specifically, Mce1R and 
Mce2R share homology with FadR repressor, which consists of a DNA-binding 
N-terminal, and acyl-CoA-binding C-terminal domains. In E coli, FadR is a 
global regulator of fatty acid metabolism, performing this function through de-
repression upon binding of long-chain fatty acid (>14 carbons) CoA thioester 
(Fujita et al., 2007). The mce1 operon is downregulated in Mtb during 
macrophage infection due to Mce1R repressor function (Casali et al., 2006), 
and Mce2R was shown to negatively regulate the mce2 operon (Santangelo et 
al., 2009). However effectors of Mce1R and Mce2R are unknown. Recently, 
stress-responsive transcription factor DosR was found to increase mce1R 
expression, which in turn would downregulate bacterial growth genes, implying 
a complicated network of regulation of bacterial replication and Mce1 function 
(Zeng et al., 2012). 
Mce3R is homologous to TetR-transcriptional factors, including FadR, 
but it’s 3D structure is more distinct from Mce1R and Mce2R (Kelly et al., 
2015). Intriguingly, 3D structure analysis revealed that its DNA-binding N-
terminal domain (8-195 aa) is identical to the one of KstR, and substrate 
12 
binding C-terminal domain (217-402 aa) aligns to acyl-CoA binding domains of 
Mtb Fad35R and Nacillus halodurans FadR. In addition to mce3 Mce3R 
negatively regulates 2 operons rv1933c–rv1935c and rv1936–rv1941 
(Santangelo et al., 2008; de La Paz et al., 2009). Interestingly, rv1933c–
rv1935c genes are also under control of the KstR repressor, supporting 
prediction of DNA-binding domain homology between Mce3R and KstR. This 
analysis reveals possible regulation of cholesterol metabolism by Mce3R 
(Wipperman et al., 2014). 
Finally, mce4 genes are regulated by cholesterol-sensing KstR 
repressor, and are induced by cholesterol (Wipperman et al., 2014; Rathor et 
al., 2016). 
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Importance of Mce complexes for infection 
Genes of the mce1 and mce4 loci were found to be a part of the genetic 
requirements for Mtb’s survival in mouse infection (Sassetti & Rubin, 2003). 
Interestingly, inactivation of mce1 produced a growth defect of Mtb during the 
first 2 weeks of infection, while mce4 mutation does not affect bacterial 
survival until after 2 weeks of infection when a T cell immune response has 
developed, enabling activation of the host leukocytes. Additionally, Pandey & 
Sassetti showed that Mce4 is required for bacterial growth only in IFN-γ 
activated macrophages (Pandey & Sassetti, 2008), and not in resting 
macrophages. 
Inactivation of both mce1 and mce4 loci has a synergistic effect on Mtb 
survival in mice (Joshi et al., 2006). 
Inactivation of mce2 and mce3 operons in Mtb results in attenuation of 
Mtb in mouse infection, manifested in no increase of bacterial counts 
compared to initial inoculum and in better survival of infected mice (Gioffré et 
al., 2005; Marjanovic et al., 2010). 
Inactivation of mceG, encoding a putative ATPase predicted to be 
required for function of all Mce1-4 transporters, leads to ~10 fold decrease in 
Mtb numbers in murine lungs (compared to the initial inoculum) by the end of 5 
weeks of infection which manifests in ~4 log difference compared to the 
infection with the wild type strain (Joshi et al., 2006). This data indicates the 
essential role of MceG and possibly linked to it Mce1-4 transporters for Mtb 
during infection. 
14 
We should point out that the majority of these experiments were 
performed with an intravenous or intraperitoneal route of infection (as opposed 
to the natural aerosol route), and CFU counts were determined from the 
spleen, not from the lung. 
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Substrates for Mce transporters in Mtb 
The first Mce protein complex for which function was characterized in 
Mtb was Mce4, a cholesterol transporter. However, mutants defective in mce4 
showed residual cholesterol uptake activity and ability to grow in media with 
cholesterol as a single carbon source (Pandey & Sassetti, 2008). This 
indicates presence of an alternative cholesterol transporter in Mtb, possibly 
Mce3 (Wipperman et al., 2014). 
The mce1 locus is preceded by fadD5 encoding fatty acyl-coenzyme A 
synthetase (Figure 1.1), responsible for the first modification that fatty acid 
undergoes once it enters the cytosol which solubilizes it for downstream 
reactions. FadD5 is important in controlling bacterial numbers in a mouse 
infection (Dunphy et al., 2010). Taken together with similarity of Mce1R to the 
FadR repressor, we could suggest that Mce1 functions as a fatty acids 
transporter. Given the importance of Mce1 for Mtb in a mouse infection, there 
were few attempts to assign function to this ABC transporter complex. As 
inactivation of mce1 in Mtb causes perturbation in mycolic acid content 
(Dunphy et al., 2010; Forrellad et al., 2014; Queiroz et al., 2015), which results 
in the inability of infected macrophages to produce a proinflammatory 
response (Shimono et al., 2003), it was suggested that Mce1 moves mycolic 
acids in the mycobacterial cell wall to maintain its homeostasis. Additionally, a 
marginal defect in palmitic acid transport was found in the ∆mce1 mutant 
(Forrellad et al., 2014). It is important to note that inability to import fatty acids 
could result in changes of mycobacterial mycolic acid content, since Mtb uses 
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long-chain fatty acids as substrates for FASII elongation to produce these 
lipids. In the absence of the extracellular fatty acids, Mtb would have to either 
synthesize fatty acids de novo or to recycle them from other lipids, which 
would be energy-costly. Further investigation of substrate specificity for Mce1 
is needed. 
Similarly, changes in sulfolipid-1 content observed in Mtb with disrupted 
mce2 could result from a defect in fatty acid/cholesterol uptake causing an 
imbalance in their metabolism (Marjanovic et al., 2011). Considering the 
homology of the transcriptional repressor Mce2R to FadR, we hypothesize that 
Mce2 functions as an alternative fatty acid transporter. 
The genome of the pathogen Mycobacterium leprae, a close relative of 
Mtb, contains only one mce operon, a homologue of mce1. M. leprae is fully 
capable of importing and metabolizing palmitate when the bacteria are 
recovered from animal tissues (Franzblau, 1988), supporting the role of Mce1 
as a fatty acid transporter. M. leprae lacks almost all of the genes encoding for 
cholesterol catabolic pathways, except for the very first one, which converts 
cholesterol to cholestenone. Interestingly, this pathogen still imports 
cholesterol, and performs this very first reaction (Marques et al., 2015), 
indicating that cholestenone might serve as a signal molecule, and raising a 
question of which alternative cholesterol transporter is used in M. leprae. 
  
17 
Role of SBPs and accessory proteins in Mce transporters 
In addition to actinobacteria, Mce proteins are also found in double-
membraned bacteria (Casali & Riley, 2007) and eukaryotic chloroplasts (Awai 
et al., 2006). Although Mtb is considered a gram-positive bacterium, its outer 
layer of the cell wall is comprised of complex lipids, resembling the cell wall 
structure of gram-negative bacteria (Figure 1.3). Therefore analysis of 
organization of Mce complexes in gram-negative bacteria could allow better 
understanding of mechanisms of lipid transport through these transporters in 
Mtb. 
 
Figure 1.3. Cell wall structures of gram-negative, gram-positive bacteria 
and mycobacteria. Adapted from (Brown et al., 2015). 
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E. coli complex homologous to Mce that is involved in delivery of lipids 
from the outer to the cytoplasmic membrane was recently characterized 
(Ekiert et al., 2016; Thong et al., 2016). It consists of MlaE permease and 
MlaF ATPase subunits along with additional proteins MlaD and MlaC. MlaD in 
the form of a homo-hexamer along with MlaC bind lipids and resemble SBPs 
of the Mce complex. These SBPs were proposed to function in binding and 
shuttling of the substrates between the outer membrane and inner membrane, 
however directionality of this transport has not been determined. 
Mce1 and Mce4 protein complexes are secreted onto the surface of 
Mtb through the SecA2-dependent protein export system (McCann et al., 
2011; Feltcher et al., 2015). YrbE1B permease is localized in cytoplasmic 
membrane, while SBPs Mce1A, Mce1B, Mce1C and Mce1E are found 
preferentially in the cell wall with partial localization to the cytoplasmic 
membrane (Forrellad et al., 2014). Interestingly, six Mce SBP’s found in each 
Mce1-4 transporter complex resemble homo-hexamer structure of MlaD in E. 
coli. Therefore, by comparing Mce transporters of Mtb to the Mla complex of E. 
coli, we can hypothesize that Mce SBP’s are responsible for binding/shuttling 
of substrates across the cell wall of Mtb to deliver them to YrbE permease, 
which will complete the import by pushing substrates through the cytoplasmic 
membrane into the cytosol. 
Activity of ABC transporters for the most part is determined through 
interaction with accessory subunits that can perform a variety of functions 
(Biemans-Oldehinkel et al., 2006). For instance, membrane-embedded 
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accessory proteins of endoplasmic reticulum membrane transporter 
associated with antigen processing (TAP) complex are essential for 
recruitment of tapasin, a glycoprotein responsible for interaction between TAP 
and MHC class I molecules (Procko et al., 2005). Therefore, such membrane 
accessory proteins can perform an adapter function to recruit interacting 
partners to the transporter. The cytosolic accessory domain of ATPase MalK, 
which supplies energy for maltose transporter in enteric bacteria, performs 
dual function (Böhm & Boos, 2004). First, it serves as a binding site for 
regulatory enzyme IIAglc when glucose is abundant, which results in 
inactivation of maltose import. Second, it inhibits activity of MlaT, a positive 
transcription regulator of maltose regulon. In result, bacteria metabolize 
glucose (a better energy source) when it is available, halting import of maltose. 
The exact function of accessory subunits in Mtb still needs to be 
determined. Orphaned accessory Rv0199/OmamA protects Mce1 SBPs from 
degradation in Mtb (Perkowski et al., 2016). Mtb cultures grown in rich media 
demonstrated an abundant presence of Mce1C degradation products in the 
cell membrane and extracellularly, suggesting possible regulation of Mce1 
function by protease activity (Forrellad et al., 2014). 
  
20 
Summary 
One of the mechanisms of Mtb’s adaptation to infection is its ability to acquire 
host-derived lipids: fatty acids and cholesterol. Mce4 ABC transporter was 
found to be responsible for cholesterol import in Mtb, however a fatty acid 
transporter still needs to be identified. How Mce transporters are regulated is 
also unknown. Improved understanding of mechanisms used by Mtb for lipid 
assimilation will determine points of vulnerability of Mtb inside its host. 
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CHAPTER 2 
 
Rv3723/LucA coordinates fatty acid and cholesterol uptake in 
Mycobacterium tuberculosis1 
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Abstract 
Pathogenic bacteria have evolved highly specialized systems to extract 
essential nutrients from their hosts and Mycobacterium tuberculosis (Mtb) 
scavenges lipids (cholesterol and fatty acids) to maintain infections in 
mammals. The mechanisms and proteins responsible for the import of fatty 
acids in Mtb were previously unknown. Here, we identify and determine that 
the previously uncharacterized protein Rv3723/LucA functions to integrate 
cholesterol and fatty acid uptake in Mtb. Rv3723/LucA interacts with subunits 
of the Mce1 and Mce4 complexes to coordinate the activities of these nutrient 
transporters by maintaining their stability. We also demonstrate that Mce1 
functions as a fatty acid transporter in Mtb and determine that facilitating 
cholesterol and fatty acid import via Rv3723/LucA is required for full bacterial 
virulence in vivo. These data establish that fatty acid and cholesterol 
assimilation are inexorably linked in Mtb and reveals a key function for 
Rv3723/LucA in coordinating both transport activities. 
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Introduction 
Mycobacterium tuberculosis (Mtb), the causative agent of human 
tuberculosis (TB), is responsible for more than 1 million deaths each year and 
the bacterium currently infects nearly ~1.5 billion individuals. A hallmark of TB 
is that infected individuals rarely develop active TB disease and most 
infections (~90%) remain in a latent or asymptomatic state. Mtb is exquisitely 
adapted to survive within the human host and the bacterium’s ability to 
metabolize host-derived lipids (fatty acids and cholesterol) is thought to enable 
bacterial persistence for long periods of time. Thus, elucidating the 
mechanisms involved in nutrient uptake and metabolism in Mtb will help us 
better understand important host-pathogen interactions of this disease and 
may identify new vulnerabilities for drug discovery. 
Multiple lines of evidence indicate that host lipids (fatty acids and 
cholesterol) serve as critical carbon sources for Mtb during infection. In the 
1950’s it was determined that Mtb propagated in mammalian tissues 
preferentially metabolizes fatty acids (Bloch & Segal, 1956) and numerous 
studies since have repeatedly demonstrated that lipid metabolism promotes 
Mtb survival during infection (McKinney et al., 2000; Muñoz-Elías et al., 2006; 
Marrero et al., 2010). Mtb also has the ability to metabolize cholesterol (Van 
der Geize et al., 2007) and the utilization of this nutrient is critical for Mtb 
survival within macrophages (VanderVen et al., 2015) and in various in vivo 
infection models (Chang et al., 2007; Pandey and Sassetti, 2008; Yam et al., 
2009; Hu et al., 2010; Nesbitt et al., 2010).  
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Although Mtb’s remarkable capacity to assimilate and metabolize lipids 
is considered a defining characteristic of this pathogen (Cole et al., 1998), the 
mechanisms underlying fatty acid uptake by Mtb have remained unknown. The 
mycolic acid-containing cell envelope of Mtb constitutes a unique barrier for 
the import of hydrophobic molecules and likely explains why the Mtb genome 
does not encode canonical fatty acid transporters that are typically found in 
other bacterial systems (Black et al., 1987; Theodoulou et al., 2016; van den 
Berg et al., 2004). Instead, it is thought that Mtb uses Mce proteins to import 
hydrophobic nutrients across the bacterial cell envelope. The Mce family of 
proteins in Mtb were originally associated with mammalian cell entry (Arruda et 
al., 1993) and are classified as part of the MlaD superfamily (cl27420) based 
on the presence of one or more Mce domains (Casali & Riley, 2007). Proteins 
containing Mce domains have been implicated in the transport of hydrophobic 
molecules in various bacteria and chloroplasts (Awai et al., 2006; Mohn et al., 
2008; Xu et al., 2008; Malinverni & Silhavy, 2009; Roston et al., 2011; Sutterlin 
et al., 2016). The aggregate data now indicate that Mce proteins mediate 
transport of hydrophobic molecules across double-membranous structures in 
cells (Thong et al., 2016; Ekiert et al., 2017). Mtb imports cholesterol across 
the mycobacterial cell envelope via the multi-subunit Mce transporter, termed 
Mce4 (Pandey & Sassetti, 2008) and the Mtb genome contains four total 
unlinked mce loci (mce1-mce4). Although the functions of proteins encoded in 
the mce1-mce3 loci are unknown; the similarities shared across the mce1-4 
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loci suggest that these loci all encode transporters responsible for the 
assimilation of hydrophobic substrates in Mtb. 
Most of the genes required for the growth of Mtb on cholesterol as a 
sole carbon source have been mapped (Griffin et al., 2011) but little is known 
about how Mtb utilizes cholesterol in the presence of other nutrients. Mtb can 
co-metabolize simple carbon substrates in vitro (de Carvalho et al., 2010), 
which suggests that the bacterium has the capacity to utilize fatty acids and 
cholesterol simultaneously in vivo. Mtb likely encounters both fatty acids and 
cholesterol during infection. For example, Mtb can induce foamy macrophage 
formation and can reside within these fatty acid and cholesterol-loaded cells 
(Peyron et al., 2008). It is also thought that Mtb is capable of persisting within 
the necrotic centers of human granulomas, an environment that is rich in fatty 
acids and cholesterol (Kim et al., 2010). Mtb also has the capacity to 
metabolically integrate the utilization of fatty acids and cholesterol when 
growing in macrophages where Mtb utilizes fatty acids to balance the 
incorporation of cholesterol-derived metabolic intermediates into biosynthesis 
of bacterial cell wall lipids (Lee et al., 2013).  
Here we performed a forward genetic screen to identify Mtb mutants 
defective in cholesterol utilization when the bacteria are grown in the presence 
of fatty acids. We identified Rv3723, a protein of unknown function, and 
determined that this protein is required for the import of both fatty acids and 
cholesterol by Mtb during growth in macrophages and in axenic culture. Thus, 
we renamed this previously uncharacterized protein Rv3723, as LucA (lipid 
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uptake coordinator A). We determined that LucA facilitates fatty acid and 
cholesterol uptake in Mtb by stabilizing protein subunits of the Mce1 and Mce4 
transporters. These studies also establish that the Mce1 complex transports 
fatty acids into Mtb and that LucA is required for full virulence in vivo. 
Together, these findings demonstrate that fatty acid and cholesterol import in 
Mtb is integrated via LucA and that coordination of these activities is 
necessary to support Mtb pathogenesis. 
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Materials and Methods 
Bacteria and growth conditions 
M. tuberculosis strains were routinely grown at 37°C in 7H9 (broth) or 
7H11 (agar) media supplemented with OAD enrichment (oleate-albumin-
dextrose-NaCl), 0.05% glycerol and 0.05% tyloxapol (broth). AD enrichment 
consisted of fatty acid free albumin-dextrose-NaCl. 7H9-based minimal 
medium is composed of Difco Middlebrook 7H9 powder 4.7 g/liter, 100 mM 2-
(N-morpholino)ethanesulfonic acid pH 6.6, and carbon sources as indicated. 
Cholesterol was added to the liquid and solid media as tyloaxapol:ethanol 
micelles as described (Lee et al., 2013). Hygromycin 100 μg/ml, kanamycin 25 
μg/ml, streptomycin 50 μg/ml, and apramycin 50 μg/ml were used for 
selection. For E. coli selection hygromycin was used at 150 μg/ml. 
Transposon screen and strain construction 
A library of transposon mutants (~105) in a Δicl1 deficient strain of Mtb 
described by (Lee et al., 2013) was plated onto 7H11 OAD agar containing 
100 μM cholesterol. Individual mutants were recovered in culture. 
Chromosomal DNA was isolated and the transposon insertion sites were PCR 
amplified and sequenced according to (Prod'hom et al., 1998). Mutant strains 
of Mtb were generated by allelic exchange (Mann et al., 2011) using a 
hygromycin resistance cassette mutant. Allelic exchange was confirmed by 
sequencing and/or Southern analysis using the Direct nucleic acid labeling 
and detection kit, GE Health Care. All the strains used in the study are 
summarized in Table 2.1. 
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Table 2.1. Strains used in the study 
 
 
Radiorespirometry assays 
Lipid oxidation was monitored by quantifying the release of 14CO2 from 
[4-14C]-cholesterol, [14C(U)]-palmitate, and [1-14C]-oleate by radiorespirometry 
as described (VanderVen et al., 2015). Briefly, Mtb cultures were pre-grown in 
7H9 AD for 5 days. Then they were incubated at OD600 of 0.7 in 5 ml 7H9 AD 
spent medium supplemented with 1.0 μCi of radiolabeled substrates in vented 
standing T-25 tissue culture flasks placed in a sealed air-tight vessel with an 
open vial containing 0.5 ml 1.0 M NaOH at 37°C. After 5 hours, the NaOH vial 
was recovered, neutralized with 0.5 ml 1.0 M HCl, and the amount of base 
soluble Na2
14CO3 was quantified by scintillation counting. The radioactive 
signal was normalized to the relative levels of bacterial growth by determining 
the OD600 for the bacterial cultures. % CO2 release was expressed as a ratio 
of normalized radioactive signal for each strain relative to the wild type control. 
Strain Location of hygromycin resistance cassette insertion Background
Δicl1 ::hyg McKinney et al . (2000) Nature 406 , 735-738 M. tuberculosis  H37Rv
Δicl1 ::hyg,  lucA ::TnHimar Mycomar tranposon insertion at 67 bp of rv3723 M. tuberculosis  H37Rv Δicl1
ΔlucA ::hyg  (283-469 bp) of rv3723  M. tuberculosis  Erdman
Δmce1 ::hyg  (551 bp of rv0167 - 493 bp of Rv0174 ) in the mce1  loci  M. tuberculosis  Erdman
ΔyrbE1A ::hyg  (67-778 bp) of rv0167  M. tuberculosis  Erdman
ΔyrbE4A ::hyg  (1-764 bp) of rv3501c  M. tuberculosis  Erdman
Strain Genetic features Background
Δicl1  Tn::lucA comp  pMV306 + aacC4 (apramycin resistance) + hsp60' ::rv3723 Δicl1 ::hyg,  lucA ::TnHimar
wild type  pMV306 smyc' ::mCherry M. tuberculosis  Erdman
ΔlucA ::hyg comp  pMV306 hsp60' ::rv3723  and smyc' ::mCherry ΔlucA ::hyg
Δmce1 ::hyg comp  pMV306 hsp60' ::rv0167-rv0177 Δmce1 ::hyg
ΔyrbE1A ::hyg comp  pMV306 hsp60' ::rv0167-rv0177 ΔyrbE1A ::hyg
ΔyrbE4A ::hyg comp  pMV306 hsp60' ::rv3501c ΔyrbE4A ::hyg
LucA-GFP  pVV16 + hsp60' ::rv3723 ::GFP + smyc'::mCherry M. tuberculosis  CDC1551
wild type
(prpD' ::GFP smyc' ::mCherry)
 pVV16 + aacC4 (apramycin resistance)
+ prpD' ::GFP + smyc'::mCherry
M. tuberculosis  Erdman
ΔlucA ::hyg
(prpD' ::GFP smyc' ::mCherry)
 pVV16 + aacC4 (apramycin resistance)
+ prpD' ::GFP + smyc'::mCherry
ΔlucA ::hyg
ΔlucA ::hyg comp
(prpD' ::GFP smyc' ::mCherry)
 pVV16 + aacC4 (apramycin resistance)
+ hsp60' ::rv3723  + prpD' ::GFP + smyc'::mCherry 
ΔlucA ::hyg
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Lipid uptake assays 
Lipid uptake was quantified as described previously (Pandey & 
Sassetti, 2008; Forrellad et al., 2014) with slight modifications. Briefly, Mtb was 
cultured at an initial OD600 of 0.1 in 7H9 AD medium in vented standing T-75 
tissue culture flasks. After 5 days, cultures were normalized to OD600 of 0.7 in 
8ml using spent medium, and 0.2 μCi of radiolabeled substrates was added to 
bacteria. After 5, 30, 60 and 120 min of incubation at 37°C 1.5 ml of the 
bacterial cultures were collected by centrifugation. Each bacterial pellet was 
washed thrice in 1 ml of ice-cold wash buffer (0.1% Fatty acid free-BSA and 
0.1% Triton X-100 in PBS), fixed in 0.2 ml of 4% PFA for 1h. The total amount 
of radioactive label associated with the fixed pellet was quantified by 
scintillation counting. The radioactive signal was normalized to the relative 
levels of bacterial growth, i.e. to the OD600 of the bacterial cultures before 
addition of radioactive label. The uptake rate was calculated by applying linear 
regression to the normalized radioactive counts over time, and uptake 
efficiency was expressed as a ratio of uptake rate for each strain relative to the 
wild type control. 
Macrophage isolation and culturing 
Macrophages were differentiated using bone marrow cells from BALB/c 
mice (Jackson Laboratories, USA) and maintained in DMEM supplemented 
with 10% heat inactivated fetal calf serum, 2.0 mM L-glutamine, 1.0 mM 
sodium pyruvate, 10% L-cell-conditioned media and antibiotics (100 U/ml 
penicillin and 100 mg/ml streptomycin) at 37°C and 7.0% CO2 for 10 days 
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before infection. Human macrophages were differentiated from purified human 
peripheral blood mononuclear cells obtained from Elutriation Core Facility, 
University of Nebraska Medical Center and maintained in DMEM 
supplemented with 10% pooled heat inactivated human serum (SeraCare), 2.0 
mM L-glutamine, 1.0 mM sodium pyruvate and antibiotics (100 U/ml penicillin 
and 100 mg/ml streptomycin) at 37°C and 7.0% CO2 for 7 days before 
infection. Media without antibiotics was used for infections with Mtb. 
Transcriptional profiling 
Murine bone marrow-derived macrophages were seeded into two T-75 
tissue culture flasks (1.5x107 cells per flask) and infected with Mtb at a MOI of 
4:1 for 3 days. Bacterial RNA was isolated, amplified, dye labeled, and 
hybridized to the microarray as described (Rohde et al., 2007; Liu et al., 2016). 
Gene expression data has been deposited in the NCBI Gene Expression 
Omnibus database accession number (GSE98792) (Edgar et al., 2002). 
prpD’::GFP reporter assays  
The promoter of rv1130/prpD was fused to GFP in a replicating vector 
that constitutively expresses mCherry (Supplementary file 1) To detect prpD 
promoter activity bacteria were grown in 7H9-based minimal medium 
containing 10 mM glucose for 5 days, washed twice with PBS 0.05% tyloxapol, 
and passed to medium containing 100 μM cholesterol or propionate at the 
indicated concentration for 24 hr. The bacteria were fixed with 4% 
paraformaldehyde (PFA) and GFP expression was quantified by flow 
cytometry on a BD Biosciences LSR II flow cytometer. To detect prpD 
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promoter activity during infection bacteria grown in 7H9-based minimal 
medium containing 10 mM glucose were used to infect murine macrophages 
at an MOI of 5:1. After 24 hr infection the macrophages were fixed with 4% 
PFA, scraped into 10 ml of PBS and suspended in 1 ml of lysis buffer (0.1% 
SDS, 0.1 mg/ml Proteinase K in H20). Macrophages were lysed by 25 
passages through a 25-gauge needle, the bacteria containing cell lysate was 
centrifuged, the pellet was retained and analyzed on a BD Biosciences LSR II 
flow cytometer. Flow cytometry data was analyzed using FlowJo (Tree Star, 
Inc). 
Imaging of intracellular lipid inclusions 
Confluent monolayers of macrophages in Ibidi eight-well glass-bottom 
chambers were infected with bacteria at a MOI of 4:1. Extracellular bacteria 
were removed after 4 hours of infection. Infected macrophages were 
maintained in cell culture medium at 37°C and 7% CO2 for 3 days. Lipid 
inclusions of bacteria in macrophages were metabolically labeled with Bodipy-
C16 (final concentration 20 μM) conjugated to 1.0% de-fatted bovine serum 
albumin (BSA) for a 30 minute pulse followed by a 1 hour chase with fresh 
media. Live-cell images were acquired as described (Podinovskaia et al., 
2013). For lipid staining, macrophages were transferred onto sterile coverslips 
in 24-well plates, infected with Mtb for 3 days and fixed in 4% PFA followed by 
staining with Bodipy-493/503 (1.0 μg/ml, at room temperature for 1 hour). 
Post-acquisition, images were analyzed using Volocity (PerkinElmer Life 
Sciences).  
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Flow cytometric quantification of assimilated lipids 
Murine bone marrow-derived macrophages were seeded into T-150 
tissue culture flasks (3x107 cells per flask) and infected with Mtb at a MOI of 
4:1. After 3 days of infection Bodipy-palmitate (final concentration 8 μM) 
conjugated to de-fatted 1% BSA was added to the cells for 1 hour pulse and 
then chased with cell media for another hour. The infected macrophages were 
scraped into 15 ml of homogenization buffer (250 mM sucrose, 0.5 mM EGTA, 
20 mM HEPES, 0.05% gelatin, pH 7.0) and pelleted by centrifugation at 
514xG (1,500 rpm, Beckman Allegra 6KR centrifuge, GH-3.8 rotor), followed 
by cell lysis by 70 passages through a 25 gauge needle. 5 ml of cell lysate 
was centrifuged at 146xG (800 rpm) for 10 minutes, supernatant (suspensions 
of phagosomes) was retained and treated with 0.1% Tween-80 at 4°C for 15 
minutes to break-open Mtb containing vacuoles. Isolated bacteria were 
washed once in PBS+0.05% tyloxapol and fixed in 4% PFA. Flow cytometry 
data was collected on BD FACS LSR II and analyzed using FlowJo (Tree Star, 
Inc). 
Colocalization studies with Alexa647-dextran labeled lysosomes 
At day 3 of infection, bone marrow derived macrophages were pulse 
labeled with 50 μg/ml Alexa647-dextran for 45 minutes and chased in fresh 
media for an additional 45 minutes. Following the chase period the infected 
cells were fixed and imaged by confocal microscopy. An extended focus 
merge of the two channels and the background was used to threshold the data 
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as described (Costes et al., 2004) and colocalization was calculated using 
Volocity (PerkinElmer Life Sciences).  
Transmission electron microscopy 
Imaging was conducted as described (Podinovskaia et al., 2013). 
Tetrahydrolipstatin treatment of infected macrophages 
100 μM tetrahydrolipstatin was added to infected bone marrow derived 
macrophages at 4 hours post infection and maintained in the medium 
throughout the infection. Cells were fixed at day 3, stained with Bodipy-
493/503, and imaged by confocal microscopy. 
Protein fragment complementation screen 
Library construction and the screen were performed as described 
(Singh et al., 2006). Briefly, Mtb genomic DNA was isolated and partially 
digested with AciI and HpaII, size fractionated (0.5-2 kb), and cloned into the 
ClaI site of pUAB300 upstream of the F1,2 domain of murine dihydrofolate 
reductase. E. coli MegaXTM DH10BTM T1 (Life Technologies) electrocompetent 
cells were used for transformation. In total 5x105 independent clones were 
selected on LB hygromycin agar plates. The clone library was isolated by 
QIAGEN QIAfilter Plasmid Giga Kit and used to transform Msm mc2155 
containing pUAB200 which co-expresses the bait protein LucA fused to the F3 
(LucA-F3) domain of murine dihydrofolate reductase. In total 2x10
6 clones 
were screened on plates containing trimethoprim 30 μg/ml. Clones containing 
fragments of the Mtb dihydrofolate reductase (rv2763c/dfrA) were identified by 
PCR and removed (85.8%). Inserts from the dfrA-negative clones were 
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sequenced, and the only in-frame clone that was identified more than once (4 
times) contained first 225 bp of rv3492c/mam4B.  
Spotting two-hybrid interaction assay 
Msm was grown in modified 7H9-OAD media containing 2% glycerol, 
0.5% additional glucose and 0.05% Tween-80 shaking at 37°C. ~8.3X106 
bacteria/ml culture was grown for 5 hours before serial dilutions were made to 
spot onto agar plates containing trimethoprim at 0, 15, and 30 µg/mL.  
Quantification of protein interactions 
To quantify the strength of interactions (IC50) we used an AlamarBlue 
based approach modified from (Singh et al., 2006). Briefly, log-phase cultures 
of Msm clones were transferred into 96-well microtiter plates at a density of 
106 of cells per well. Eight 2-fold serial dilutions of trimethoprim were made for 
each clone, from 600 to 4.69 μg/ml. The final volume in the wells was 200 μl. 
After 41 hours of incubation at 37°C, 30 μl 50% AlamarBlue (Life 
Technologies) (diluted with the media) was added to the wells and after 
incubating for 20 hours the fluorescence intensity was measured in Gemini EM 
Microplate Reader (Molecular Devices) with excitation at 530nm and emission 
at 590nm. 100% inhibition was assigned to the wells without bacterial cells, 
and 0% inhibition to the wells with cells without trimethoprim. 
Antibody generation and western analysis 
Antibody for MceG was generated in rabbits using the peptide 
KAQAAILDDL conjugated to keyhole limpet hemocyanin by (Cocalico 
Biologicals). This peptide was used for antibody purification by immunoaffinity 
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chromatography. To generate the lysate bacteria were grown as for the lipid 
uptake assays. In the cases of chloramphenicol treatment, the antibiotic was 
added at 20 μg/ml 2 days prior to harvesting the bacteria.  To generate lysates 
bacteria were washed twice with PBS 0.05% tyloxapol and fixed with 4% PFA 
for 1 hour. Fixed cells were washed twice in PBS 0.05% tyloxapol and lysed 
by sonication. Protein concentrations were determined by BCA (Thermo 
Fisher Scientific) and equivalent amounts of protein were resolved by SDS-
PAGE and transferred to nitrocellulose membranes. The primary anti-Mce1A, 
anti-Mce1D and, anti-Mce1E antibodies were obtained from Christopher 
Sassetti (Feltcher et al., 2015), and the anti-GroEL antibody was obtained 
from BEI resources. A HRP-conjugated goat-anti rabbit IgG (Jackson 
ImmunoResearch) was used as the secondary antibody. ImageJ was used to 
quantify signals on Western blots. 
qPCR 
Bacteria were cultured as described for western analysis and the RNA 
was extracted and analyzed as previously described (Abramovitch et al., 
2011).  
Bacterial survival assay in macrophages 
Confluent macrophage (human and murine) monolayers in 24-well 
dishes were infected with Mtb at a MOI 4:1 for murine cells and a MOI of 0.5:1 
for the human cells. Extracellular bacteria were removed by washing with fresh 
media after 4 hours of infection. At indicated time points macrophages were 
lysed with 0.1% Tween-80 in water and the lysates were serially diluted in 
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0.05% Tween-80 in water. The lysates were plated on 7H11 OAD agar and 
CFU were quantified after 3-4 weeks incubation at 37°C.  
Mouse infections 
Eight-week-old female C57BL/6J WT mice (Jackson Laboratories) were 
infected with 1,000 CFU of Mtb Erdman (wild type, ΔlucA::hyg, complemented 
strain) via an intranasal delivery method as described (Sukumar et al., 2014). 
This was accomplished by lightly anesthetizing the mice with isoflurane and 
administering the bacteria in a 25 µl volume onto both nares. At sacrifice, the 
lungs were removed and half of the lungs were fixed in 4% PFA overnight, 
while another half was used for bacterial load quantification. For the latter, 
lungs were homogenized in PBS 0.05% Tween-80 and plated on 7H11 OAD 
agar. CFU were quantified after 3-4 weeks incubation at 37°C. 
Lung histopathology 
PFA fixed lung lobes were stained with hematoxylin and eosin by the 
Cornell Histology Laboratory. Stained sections were imaged using a Zeiss 
Axio Imager M1 equipped with an AxioCam Hrc camera. 
Ethics Statement 
All animal care and experimental protocols were in accordance with the 
NIH “Guide for the Care and Use of the laboratory Animals” and were 
approved by the Institutional Animal Care and Use Committee of Cornell 
University (protocol number 2013-0030). 
  
47 
Results 
lucA encodes a membrane protein involved in cholesterol metabolism. 
Using a forward genetic screen we identified genes involved in 
cholesterol utilization when Mtb is grown in media containing a mixture of fatty 
acids and carbohydrates. To do this we used the Mtb H37Rv mutant 
(Δicl1::hyg) (McKinney et al., 2000) which has a synthetic lethal phenotype 
and fails to grow in rich media containing cholesterol. This growth inhibition is 
linked to the accumulation of one or more toxic cholesterol-derived 
intermediates produced by the methylcitrate cycle, which accumulate in the 
bacteria when icl1 is nonfunctional (Lee et al., 2013; Eoh & Rhee, 2014; 
VanderVen et al., 2015). We reasoned that mutations in the cholesterol 
utilization pathway would rescue the growth inhibition of Δicl1::hyg by 
preventing the formation of the cholesterol-dependent toxic methylcitrate cycle 
intermediate(s) (Figure 2.1. A). Therefore, we isolated transposon rescue 
mutants in a Δicl1::hyg background that gained the ability to grow on media 
containing cholesterol.  
17 sibling mutants carrying Himar transposon insertions in the lucA 
gene (Δicl1::hyg, lucA::TnHimar) were identified with the screen, suggesting 
that lucA is required for cholesterol utilization by Mtb. Orthologs of lucA are 
restricted to Mycobacterium spp., and this gene encodes an uncharacterized 
putative integral membrane protein. Additionally, previous genetic epistasis 
studies implicated lucA in cholesterol utilization in vivo (Joshi et al., 2006), but, 
the function of this gene/protein has not yet been described. Using genetic 
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complementation we confirmed that the transposon insertion in the lucA gene 
is responsible for the growth rescue of the Δicl1::hyg, lucA::TnHimar mutant in 
cholesterol-containing media (Figure 2.1. B). To ascertain subcellular 
localization, the LucA protein was fused to green fluorescent protein (LucA-
GFP) and expressed in a wild type strain of Mtb that constitutively expresses a 
cytosolic mCherry fluorescent protein. Confocal microscopy revealed a 
peripheral distribution for LucA-GFP, which is consistent with LucA having a 
cell membrane or cell envelope localization (Figure 2.1. C).  
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LucA facilitates cholesterol uptake and metabolism. 
Given the potential role of LucA in cholesterol metabolism, we 
constructed a lucA mutant in Mtb Erdman by allelic exchange (Mtb 
ΔlucA::hyg). We first quantified cholesterol metabolism in the ΔlucA::hyg 
mutant by measuring the catabolic release of 14CO2 from [4-
14C]-cholesterol 
(VanderVen et al., 2015). This assay detected a ~90% reduction in the amount 
of 14CO2 released from [4-
14C]-cholesterol in the ΔlucA::hyg mutant relative to 
the wild type and the complemented strains (Figure 2.1. D). The reduction in 
14CO2 release was not due to a growth defect of the mutant (Figure 2.1. E) and 
the percent 14CO2 released was normalized to bacterial biomass.  
To determine if lucA is required for cholesterol uptake in Mtb we next 
quantified the rate of [4-14C]-cholesterol uptake using an established assay 
(Pandey & Sassetti, 2008). We found that the ΔlucA::hyg mutant assimilates 
~70% less cholesterol relative to the wild type and complemented controls 
(Figure 2.1. F). The cholesterol uptake rates were derived from the bacterial 
associated radioactive counts (Figure 2.1. G) and the cholesterol uptake rate 
in wild type was set to 100% and the rates for the other strains were 
expressed as a ratio relative to wild type. The levels of cholesterol metabolism 
and uptake in the ΔlucA::hyg strain was comparable to a Mtb Erdman mutant 
lacking the permease subunit of the Mce4 cholesterol transporter 
Rv3501c/YrbE4A (ΔyrbE4A::hyg) (Figure 2.1. D,F,G). The residual cholesterol 
that is imported in the ΔyrbE4A::hyg mutant may be transported by an 
unknown alternative cholesterol transporter in Mtb. Together these data 
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demonstrate that lucA is required for the uptake of cholesterol and the 
subsequent metabolism of the sterol. 
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Figure 2.1. LucA facilitates cholesterol uptake in Mtb. A Schematic 
detailing cholesterol toxicity in Δicl1::hyg Mtb. B Complementation with lucA 
restores cholesterol toxicity in the Δicl1::hyg lucA::TnHimar mutant. C Wild 
type Mtb constitutively expressing cytosolic mCherry and LucA-GFP. Left 
panel, a z-slice in the green channel alone (green = LucA-GFP) and the right 
panel, overlaid green and red channels (red = mCherry Mtb) for the same 
optical slice. Scale bar 1.0 μm D The ΔlucA::hyg and ΔyrbE4A::hyg mutants 
are defective in the catabolic release of 14CO2 from [4-
14C]-cholesterol. Data 
are means ± SD (n = 4). E The ΔlucA::hyg mutant has no growth defect in the 
7H9 AD media used for uptake and metabolism experiments. Data are means 
± SD (n = 3). F The ΔlucA::hyg and ΔyrbE4A::hyg mutants are defective in 
cholesterol uptake. Data are means ± SD (n = 4). G Representative 14C-
cholesterol uptake data used to calculate cholesterol uptake rates. Data 
shown is representative of one independent experiment with two biological 
replicates. 
*p < 0.0005, **p < 0.005, ***p < 0.05 (Student’s t test).  
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The ΔlucA::hyg mutant is defective in cholesterol utilization during 
infection in macrophages. 
We next analyzed the transcriptional profile of the ΔlucA::hyg mutant 
during macrophage infection. These experiments revealed that the KstR 
regulon was strongly down-regulated in the ΔlucA::hyg mutant (Figure 2.2). 
The KstR regulon is controlled by the transcriptional repressor, KstR which 
regulates expression of the genes encoding enzymes responsible for 
metabolizing the side chain and A/B rings of cholesterol (Kendall et al., 2007). 
The KstR regulon is activated in a “feed forward” manner when KstR is de-
repressed by binding to the second cholesterol degradation intermediate, 3-
oxocholest-4-en-26-oyl-CoA (3OCh-CoA) (Ho et al., 2016). Thus, down-
regulation of the KstR regulon in the ΔlucA::hyg mutant is consistent with a 
decrease in cholesterol uptake by the ΔlucA::hyg mutant and suggests that 
3OCh-CoA may not be produced to levels that are sufficient to de-repress the 
KstR regulon in the mutant during infection in macrophages.  
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Figure. 2.2. Transcriptional profile of the ΔlucA::hyg mutant during 
infection in macrophages. Bacterial gene expression profiles were 
determined at day 3-post infection in resting murine macrophages. Gene 
expression values from the ΔlucA::hyg mutant (Δ) and complement (C) strains 
were normalized to wild type. Data represent means (n = 3). 
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Mtb assimilates cholesterol-derived propionyl-CoA into its central 
metabolism via the methyl-malonyl pathway and the methylcitrate cycle and 
the genes encoding enzymes of these pathways are normally highly 
expressed when Mtb metabolizes cholesterol (Savvi et al., 2008; Griffin et al., 
2012). We found that expression of the methyl-malonyl and the methylcitrate 
cycle genes were also down-regulated in the Mtb ΔlucA::hyg mutant (Figure 
2.2). In Mtb propionyl-CoA, activates the rv1130/prpD promoter to enhance the 
bacterium’s ability to assimilate cholesterol-derived metabolic intermediates 
via the methyl-citrate pathway (Griffin et al., 2012; Masiewicz et al., 2012). 
Thus, to monitor cholesterol breakdown in Mtb during infection in 
macrophages we constructed a reporter vector where the rv1130/prpD 
promoter controls GFP expression while mCherry is constitutively expressed 
(prpD’::GFP smyc’::mCherry). We validated this reporter strain and determined 
by flow cytometry that GFP fluorescence increased >20-fold in wild type Mtb 
when the bacteria were grown in media containing cholesterol or propionate 
(Figure 2.3. A,B). Using this reporter we observed a ~75% reduction in GFP 
fluorescence in the ΔlucA::hyg strain relative to the wild type and 
complemented strain controls when the bacteria were grown in media 
containing cholesterol (Figure 2.3. C). We also quantified GFP fluorescence in 
the Mtb ΔlucA::hyg strain during infection in macrophages. To do this, 
intracellular bacteria were isolated from the infected macrophages and 
bacterial GFP fluorescence was quantified by flow cytometry. This analysis 
also demonstrated a ~75% reduction in GFP fluorescence in the Mtb 
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ΔlucA::hyg strain (Figure 2.3. D) supporting the idea that the Mtb ΔlucA::hyg 
mutant is defective in assimilating cholesterol during infection in macrophages.  
 
 
Figure 2.3. Inactivation of LucA leads to defect in prpD expression. A 
Flow cytometery-based analysis of wild type Mtb carrying the prpD promoter 
reporter (prpD’::GFP smyc’::mCherry) confirms that this strain expresses GFP 
in response to cholesterol (100 μM) or propionate (300 μM) but not glucose 
(200 μM). B Quantification of GFP expression of wild type Mtb carrying the 
prpD promoter reporter in media containing the indicated carbon source. C 
The ΔlucA::hyg mutant carrying the prpD reporter has a decrease in GFP 
expression in cholesterol media. D The ΔlucA::hyg mutant carrying the prpD 
reporter has a decrease in GFP expression during infection of murine 
macrophages. Data are means ± SD (n=3) and for flow cytometery analysis, 
>10,000 individual bacteria were analyzed. 
*p < 1*10-6, **p < 5*10-6, ***p < 5*10-8 (Student’s t test). 
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The Mtb ΔlucA::hyg mutant does not assimilate fatty acids during 
macrophage infection. 
Unexpectedly, the transcriptional response of the Mtb ΔlucA::hyg 
mutant also revealed a gene expression signature that is consistent with a 
defect in fatty acid utilization. For these analyses, we focused on the Mtb 
genes that are induced during infection in macrophages and during growth in 
axenic media containing palmitate (Schnappinger et al., 2003). The majority of 
these genes were strongly down-regulated in the ΔlucA::hyg mutant indicating 
a defect in fatty acid assimilation by the mutant (Figure 2.2).  
To confirm that the ΔlucA::hyg mutant has a fatty acid utilization defect 
during infection in macrophages, we next quantified import of fluorescently 
labelled palmitate (Bodipy-C16) by the intracellular bacteria. Resting murine 
macrophages were infected with wild type, ΔlucA::hyg mutant, and 
complemented strains, all of which constitutively express mCherry. On day 3, 
the infected macrophages were pulsed with Bodipy-C16 and confocal analysis 
revealed that the wild type and the complemented bacteria accumulated 
intracellular Bodipy-C16 as visible punctate inclusions, while the ΔlucA::hyg 
mutant did not (Figure 2.4. A). To corroborate this finding, the bacteria were 
isolated from Bodipy-C16 pulse-labeled macrophages and we quantified the 
amount of Bodipy-C16 assimilation by flow-cytometry. This analysis revealed a 
10-fold reduction in the amount of Bodipy-C16 assimilated by the Mtb 
ΔlucA::hyg mutant relative to the wild type and complemented strains (Figure 
2.4. B). The decrease in Bodipy-C16 assimilation by the ΔlucA::hyg mutant is 
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not due to a loss of bacterial viability since there was minimal difference in 
bacterial colony forming units (CFU) at day 3 of these experiments (Figure 2.4. 
C).  
 
Figure 2.4. LucA facilitates fatty acid uptake during macrophage 
infection. A Bodipy-C16 does not accumulate in ΔlucA::hyg mutant as 
cytosolic lipid inclusions. Representative confocal images of infected 
macrophages (red = mCherry Mtb, green = Bodipy-C16). Scale bar 5.0 μm. B 
Flow cytometry quantification of Bodipy-C16 incorporation by Mtb isolated 
from pulse labeled macrophages. Shaded histogram represents 
autofluorescence in the green channel. C Bacterial viability determined at day 
3-post infection from infected macrophages. Data are means ± SD (n = 3).  
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Mtb principally resides in an intracellular macrophage compartment that 
resembles an early endosome that fails to fuse with lysosomes (Russell et al., 
2010). It is possible that the ΔlucA::hyg mutant is aberrantly trafficked to 
lysosomal compartments in the macrophage and this could potentially restrict 
access of Bodipy-C16 to the intracellular mutant. To rule this out, lysosomes 
were pulse labeled with Alexa647-dextran and at day 3 of infection we 
determined that wild type, the ΔlucA::hyg mutant, and complemented strain 
did not co-localize with the Alexa647-dextran-loaded lysosomes with Pearson 
coefficient of correlation values of 0.052±0.062 (wild type), 0.101±0.054 
(ΔlucA::hyg), and 0.190±0.174 (complemented strain) (Figure 2.5. A).  
 During infection Mtb can sequester and store fatty acids as 
triacylglycerol (TAG) within cytosolic intracellular lipid inclusions in the bacteria 
(Daniel et al., 2011). Therefore, the presence of lipid inclusions can serve as 
an indicator of fatty acid assimilation by Mtb during infection. To image 
intracellular lipid inclusions in Mtb we used the neutral lipid stain Bodipy-
493/503 (Listenberger & Brown, 2007). Staining infected murine macrophages 
with Bodipy-493/503 revealed a punctate staining pattern in the wild type and 
complemented strains while no staining was observed in the Mtb ΔlucA::hyg 
mutant (Figure 2.5. B). The lack of Bodipy-493/503 staining in the ΔlucA::hyg 
mutant indicates that this strain does not accumulate fatty acids during 
infection in macrophages. Lipid inclusions in Mtb can also be visualized by 
transmission electron microscopy and we observed that only ~5% of the 
ΔlucA::hyg mutant cells had identifiable lipid inclusions, while ~25% of the wild 
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type and ~35% of complemented bacteria had visible cytosolic lipid inclusions 
during infection in macrophages (Figure 2.5. C,D). 
The apparent decrease in cytosolic lipid inclusions within the ΔlucA::hyg 
mutant during infection in macrophages could also be due to enhanced 
bacterial turnover of the intracellular TAG in the mutant strain. To rule this 
possibility out, we treated the ΔlucA::hyg mutant bacteria with the broad-
spectrum lipase inhibitor, tetrahydrolipstatin (THL) during infection in 
macrophages. It has been reported that THL can inhibit TAG turnover in Mtb 
(Baek et al., 2011). We predicted that if TAG were more efficiently degraded in 
the Mtb ΔlucA::hyg mutant, THL treatment would restore the presence of 
intracellular lipid inclusions in this mutant. Visualizing cytosolic bacterial lipid 
inclusions with Bodipy-493/503 following THL treatment revealed that THL had 
no effect on presence of intracellular lipid inclusions in the ΔlucA::hyg mutant 
(Figure 2.5. E). Together, these observations indicate that the Mtb ΔlucA::hyg 
mutant is unable to utilize both fatty acids and cholesterol during infection in 
macrophages. 
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Figure 2.5. LucA facilitates accumulation of lipid inclusions in Mtb during 
macrophage infection. A Three-dimensional reconstructions of infected 
macrophages labeled with Alexa647-dextran (green = lysosomes, red = Mtb). 
B The ΔlucA::hyg mutant does not accumulate Bodipy-493/503 positive 
intracellular lipid inclusions (red = Mtb, green = Bodipy-493/503). Scale bar, 
5.0 μm. C Transmission electron microscopy reveals that lipid inclusions 
(indicated by asterisks) are not apparent in the ΔlucA::hyg mutant. Scale bar 
0.5 μm. D Quantification of intracellular Mtb containing lipid inclusions per 
macrophage section. Horizontal bars are means ± SD (n = 20). E THL treating 
of the ΔlucA::hyg strain does not induce intracellular lipid inclusions that are 
positive with Bodipy-493/503 (red = Mtb, green = Bodipy-493/503). 
*p < 0.0005, **p < 0.0001 (Student’s t test) 
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LucA facilitates fatty acid uptake. 
Our studies using the macrophage infection model indicate that the 
ΔlucA::hyg mutant has a defect in fatty acid assimilation. Therefore, we next 
quantified fatty acid metabolism and uptake in the Mtb ΔlucA::hyg mutant 
using radiolabeled fatty acids in axenic culture. Fatty acid metabolism was 
measured by quantifying the catabolic release of 14C-CO2 from [
14C(U)]-
palmitate and [1-14C]-oleate. This assay detected a ~80% and ~95% reduction 
in the ΔlucA::hyg mutant’s ability to metabolize the [14C(U)]-palmitate and [1-
14C]-oleate, respectively (Figure 2.6. A,D). We used both of these lipid 
substrates because palmitate and oleate are the dominant fatty acid species 
found in mammalian cell membranes and we wanted to evaluate uptake of 
both saturated (palmitate) and unsaturated (oleate) substrates.   
Fatty acid uptake was quantified with [14C(U)]-palmitate and [1-14C]-
oleate similar to cholesterol uptake experiments. Relative to the wild type and 
complemented strains we observed a ~90% and ~95% reduction in the 
ΔlucA::hyg mutant’s ability to assimilate [14C(U)]-palmitate and [1-14C]-oleate, 
respectively (Figure 2.6. B,C,E,F). Based on these results we conclude that 
inactivating lucA perturbs fatty acid uptake by Mtb, which decreases the 
bacterium’s ability to metabolize fatty acids. 
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Figure 2.6. LucA facilitates fatty acid uptake in axenic culture. A and D 
Catabolic release of 14CO2 from [
14C(U)]-palmitic acid or [1-14C]-oleic acid. 
Data are means ± SD (n ≥ 4). B and E Uptake of [14C(U)]-palmitic acid or [1-
14C]-oleic acid. Data are means ± SD (n ≥ 4). C and F Representative 14C-
palmitate and 14C-oleate uptake data used to calculate fatty acid uptake rates. 
G The catabolic release of 14CO2 from [4-
14C]-cholesterol by the ΔyrbE1A::hyg 
mutant. Data are means ± SD (n ≥ 4). H Uptake of [4-14C]-cholesterol for the 
ΔyrbE1A::hyg mutant (data are means ± SD (n ≥ 4)) I representative [4-14C]-
cholesterol uptake data used to calculate cholesterol uptake rates in the 
ΔyrbE1A::hyg mutant. 
*p < 0.0005, **p < 0.0001, ***p < 0.005 (Student’s t test). 
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Mce1 is a fatty acid transporter. 
The system(s) responsible for fatty acid import in Mtb have remained 
elusive. While the ΔlucA::hyg mutant is defective in fatty acid uptake, the LucA 
protein lacks any recognizable domains that would predict a transport function 
for the protein. Thus, we hypothesized that, in the absence of lucA, Mtb may 
up-regulate expression of an actual fatty acid transporter to compensate for 
the fatty acid uptake defect observed in the mutant. Analyses of the up-
regulated genes in the ΔlucA::hyg mutant during infection in macrophages 
revealed that genes in the mce1 locus are strongly induced (Figure 2.2). Thus, 
we hypothesized that Mce1 functions as a fatty acid transporter in Mtb. To test 
this hypothesis we inactivated the Mce1 permease Rv0167/YrbE1A subunit by 
allelic exchange (ΔyrbE1A::hyg) and quantified fatty acid uptake and 
metabolism in this mutant. We found that the ΔyrbE1A::hyg mutant displayed 
a ~70% and ~85% reduction in its ability to metabolize [14C(U)]-palmitate and 
[1-14C]-oleate, respectively (Figure 2.6. A,D). Relative to the wild type and 
complemented strains we detected a ~80% and ~75% reduction in the 
ΔyrbE1A::hyg mutant’s ability to import [14C(U)]-palmitate and [1-14C]-oleate 
(Figure 2.6. B,C,E,F). Notably, ΔyrbE1A::hyg was still able to metabolize and 
import cholesterol to wild type levels (Figure 2.6. G,H,I). Lastly, we generated 
a separated mutant and inactivated 8 genes of the mce1 locus by allelic 
exchange (Δmce1::hyg). We found that the Δmce1::hyg mutant was also 
defective in fatty acid uptake and metabolism, while this mutant had no 
detectable defect in cholesterol uptake or metabolism (Figure 2.7). Based on 
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these results we conclude that the Mce1 complex functions as a dedicated 
fatty acid transporter in Mtb. 
 
 
 
Figure 2.7. Deletion of the full mce1 operon leads to fatty acid uptake 
defect. A and B the Δmce1::hyg is defective in palmitic acid metabolism and 
uptake. C and D the Δmce1::hyg mutant is defective in oleic acid metabolism 
and uptake. E and F the Δmce1::hyg mutant can metabolize and import 
cholesterol. 
Data are means ± SD (n ≥ 4). *p < 0.0001 (Student’s t test). 
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LucA interacts with Mce1- and Mce4-associated proteins. 
To shed light on the function of LucA we next conducted an unbiased 
mycobacterial 2-hybrid screen to identify protein fragments that interact with 
LucA (Singh et al., 2006). For this, the F3 domain of murine dihydrofolate 
reductase (mDHFR) was fused to the C-terminus of a full length LucA (LucA-
F3) (Table 2.2). We co-expressed LucA-F3 in M. smegmatis (Msm) along with 
a library (2x106) of random Mtb protein fragments fused to the F1,2 domain of 
mDHFR (Figure 2.8. A). Interactions between bait and prey fusions that carry 
the split domains of mDHFR confer resistance to trimethoprim in Msm. This 
protein interaction screen identified 4 sibling clones which all encode an in-
frame N-terminal fragment (1-75 aa) of the Rv3492c/Mam4B protein fused to 
the F1,2 domain of mDHFR. Mam4B is encoded by a gene within the mce4 
operon (Figure 2.8. A) and this protein is predicted to function as a subunit of 
the Mce4 cholesterol transporter complex. To validate this screen result we 
engineered a new truncated (TR) Mam4B fusion with the F1,2 domain of 
mDHFR (Mam4B(TR)-F1,2) (1-75 aa) and confirmed that co-expressing 
Mam4B(TR)-F1,2 with LucA-F3 in Msm conferred resistance to trimethoprim 
(Figure 2.8. B, Table 2.2). We found that the transmembrane (TM) segment of 
Mam4B is the portion of the Mam4B protein that interacts with LucA. Co-
expressing just the transmembrane domain (1-30 aa) of Mam4B fused to the 
F1,2 domain of mDHFR (Mam4B(TM)-F1,2) conferred trimethoprim resistance 
(Figure 2.8. B, Table 2.2).  
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The Mtb genome encodes additional homologs of Rv3492c/Mam4B that 
are associated with the Mce1 transporter. Given that the ΔlucA::hyg mutant is 
also defective in the import of fatty acids we hypothesized that LucA could also 
interact with homologous subunits of the Mce1 transporter. We focused on the 
homologous Mtb proteins Rv0175/Mam1A, Rv0177/Mam1C, Rv0178/Mam1D 
and Rv0199/OmamA because these proteins are predicted to be part of the 
Mce1 transporter (Casali & Riley, 2007; Perkowski et al., 2016) and conserve 
a similar transmembrane topology as Rv3492c/Mam4B (Figure 2.8. A). To 
determine if these subunits also interact with LucA we engineered F1,2 fusions 
with various homologs of Rv3492c/Mam4B. We found that co-expressing 
LucA-F3 with full length (FL) versions of Rv0177/Mam1C and Rv0199/OmamA 
fused to F1,2 conferred trimethoprim resistance (Figure 2.8. B, Table 2.2). 
Additionally, we found that LucA-F3 with transmembrane domains (TM) of 
Rv0177/Mam1C and Rv0199/OmamA fused to F1,2 conferred trimethoprim 
resistance (Figure 2.8. B, Table 2.2). These data indicate that LucA physically 
interacts with subunits of the Mce1 and Mce4 transporters and suggests that 
the LucA protein participates in the function of these complexes.  
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Figure 2.8. LucA interacts with subunits of Mce1 and Mce4 transporters. 
A Schematic of split-DFHR protein constructs, shading indicates proteins that 
interact with LucA and striped boxes indicate predicted transmembrane 
domains. B Serial dilutions of Msm co-expressing the LucA-F3 bait and the 
indicated prey were plated onto plates without antibiotic or plates containing 
trimethoprim at the indicated concentration. Growth on trimethoprim indicates 
protein-protein interaction. Positive is the positive control strain of Msm that 
co-expresses Saccharomyces cerevisiae homodimeric leucine zipper subunits 
(GCN4-F1,2 and GCN4-F3). Negative is the negative control strain of Msm that 
expresses LucA-F3 and GCN4-F1,2.  
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LucA stabilizes subunits of the Mce1 and Mce4 complexes. 
Recently, it was demonstrated that Rv0199/OmamA is involved in 
cholesterol metabolism and stabilizes the Mce1 complex in Mtb (Perkowski et 
al., 2016). Given that LucA interacts with Rv0199/OmamA and the related 
homologs Rv3492c/Mam4B and Rv0177/Mam1C we hypothesized that both 
the Mce1 and Mce4 transporters may also be destabilized in the ΔlucA::hyg 
mutant. To test this, we generated whole cell lysates from Mtb grown under 
the conditions used in the lipid uptake experiments. Gene expression analysis 
by qPCR confirmed that the mce1 genes are expressed in the ΔlucA::hyg 
mutant to equivalent levels relative to the wild type and complemented strains 
(Figure 2.9. A). In contrast, analysis of bacterial lysates revealed that, at the 
protein level, the putative subunits of the Mce1 complex (Mce1A, Mce1D, 
Mce1E) were completely degraded in the ΔlucA::hyg mutant (Figure 2.9. B,C). 
Unfortunately, thus far we have been unable to raise antibodies specific to the 
analogous Mce4 subunits. 
It is thought that MceG/Rv0655 functions as a common ATPase to 
hydrolyze ATP and facilitate nutrient uptake through the Mce transporters in 
Mtb (Joshi et al., 2006). MceG is required for optimum growth of Mtb on 
cholesterol and a mutant lacking MceG displays a cholesterol import defect 
that is equivalent to the cholesterol import defect observed in a mutant lacking 
Mce4 (Pandey & Sassetti, 2008). Although the role of MceG in fatty acid 
uptake has not been confirmed, it has been previously established that the 
stability of MceG requires co-expression of the Mce1 and Mce4 permease 
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subunits in mycobacterial cells (Joshi et al., 2006). To further explore the 
cholesterol and fatty acid uptake defect in the ΔlucA::hyg mutant we 
hypothesized MceG may also be degraded or destabilized in this strain. 
Therefore we quantified MceG levels in the bacterial lysates and observed a 
~30% decrease in amount of MceG in the whole cell lysates of the ΔlucA::hyg 
mutant (Figure 2.9. B). It has recently been reported that synthesis of Mce 
proteins can exceed the rates of degradation (Perkowski et al., 2016) and 
given that there is negligible difference in the expression of MceG at the RNA 
level across the strains we used chloramphenicol to suppress protein 
synthesis in the bacteria. Under this condition the relative amount of MceG 
protein decreased by ~75% in the ΔlucA::hyg mutant (Figure 2.9. B). These 
results demonstrate that, in the absence of LucA, not only subunits of the 
Mce1 transporter complex, but also shared MceG ATPase, are degraded, 
possibly due to activity of unknown specific proteases. These data provide an 
explanation for the linked defect in both fatty acid and cholesterol uptake 
observed in the ΔlucA::hyg mutant and that LucA serves to coordinate the 
uptake of these nutrients by protecting the Mce1 and Mce4 transporters from 
degradation (Figure 2.10).   
74 
 
 
 
 
Figure 2.9. LucA is required for stability of Mce1 and Mce4 subunits. A 
Quantification of RNA transcripts by qPCR from untreated bacterial strains. 
Fold change values were determined by normalizing transcript levels to the 
Mtb housekeeping gene, sigA. Data are means ± SD (n = 6). B Whole cell 
lysates probed by western blotting using antibodies specific for the indicated 
proteins. Chloramphenicol was added for 2 days before the lysate was 
prepared where indicated. Inset values indicate MceG protein levels that were 
quantified and expressed as a ratio relative to MceG in the wild type lysates. 
GroEL2 is a loading control and blots are representative of two independent 
experiments. C Organization of genes that encode the Mce1 and Mce4 
transporters. Striped arrows indicate genes encoding proteins that are 
degraded in the ∆lucA::hyg mutant. Empty arrows indicate genes encoding 
accessory proteins that interact with LucA.  
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Figure 2.10. Schematic of LucA function in fatty acid and cholesterol 
uptake. Mtb scavenges lipids from macrophage during infection. Mce1 and 
Mce4 serve as fatty acid and cholesterol importers. LucA interacts with 
subunits of these protein complexes. Inactivation of LucA leads to degradation 
of Mce1 and Mce4 subunits and renders them nonfunctional. 
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LucA contributes to the in vivo fitness of Mtb. 
These data indicate that LucA is involved in the utilization of two critical 
host-derived lipid substrates. It is known that deletion of one or both of the 
Mce1 and Mce4 transporters leads to decreased survival of the pathogen in 
mouse model infection (Joshi et al., 2006) and we predict that both of these 
transporters would be nonfunctional in the ΔlucA::hyg mutant. In human 
macrophages the ΔlucA::hyg mutant displayed a growth lag that culminates in 
a 10-fold difference in bacterial counts compared to wild type and 
complemented strains over a 7-day infection period (Figure 2.11. A). A similar 
phenotype was observed in the resting murine macrophages where the 
ΔlucA::hyg mutant replicated poorly over a 10-day infection period (Figure 
2.11. B). In both human and murine macrophages the final CFU counts for the 
ΔlucA::hyg mutant remained close to initial inoculum levels. These data are 
consistent with the hypothesis that Mtb requires LucA to sustain maximal 
growth on cholesterol and/or fatty acid substrates in macrophages.  
In the lung tissues of C57BL/6J mice, the ΔlucA::hyg mutant also 
demonstrated a fitness defect and did not attain levels of bacterial burden 
comparable to either the wild type or complemented strains. At day 14 post-
infection 10-fold fewer CFU’s of the ΔlucA::hyg mutant were recovered relative 
to wild type and the complemented strains. During the remainder of the 56-day 
infection period, growth of the ΔlucA::hyg mutant remained restricted, leading 
to 3- to 5-fold reduction in viable ΔlucA::hyg bacteria (Figure 2.11. C). The 
ΔlucA::hyg mutant also induced less pulmonary pathology throughout the 
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entire course of infection (Figure 2.11. D). Complementation almost 
completely restored pathogenicity and lung tissue pathology confirming the 
specificity of the mutant phenotype to the lucA gene.  
 
 
Figure 2.11. LucA is required for the full fitness of Mtb in macrophages 
and survival in mouse lungs. A Bacterial replication in resting human 
monocyte derived macrophages. Data are means ± SD (n = 3). B Bacterial 
replication in resting murine bone marrow derived macrophages. Data are 
means ± SD (n = 3). C Bacterial survival in mouse lung tissues. Data are 
means ± SD (n = 5 per time point) D Lung pathology of infected mice collected 
at indicated time points and H&E stained. Scale bar 400 μm. 
*p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0005 (Student’s t test). 
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Discussion 
While there is general agreement as to the role of Mce4 in cholesterol 
uptake in Mtb, the process of fatty acid assimilation by the bacterium has 
remained enigmatic. These data shed new light on the coordination of fatty 
acid and cholesterol import and reveal that a network of proteins associates 
with the Mce1 and Mce4 transporters to integrate the uptake of both fatty acids 
and cholesterol.  
Using an unbiased forward genetic screen we discovered that 
transposon insertions in the lucA gene rescue cholesterol toxicity in an Mtb 
strain that lacks Δicl1. Subsequent analysis confirmed that mutation of lucA 
(ΔlucA::hyg) has a profound impact on cholesterol uptake, and that this 
cholesterol uptake defect confers growth rescue in the Δicl1 lucA::TnHimar 
double mutant.  
Transcriptional profiling revealed that genes normally activated by 
cholesterol are down-regulated in the ΔlucA::hyg mutant during infection in 
macrophages. This is consistent with a defect in cholesterol uptake in this 
mutant. We were surprised to discover that the ΔlucA::hyg mutant also 
produces a gene expression signature indicative of a fatty acid metabolism 
defect. Although the functions for many of these “fatty acid-induced” genes are 
unknown, their expression pattern serves as a reliable indicator of a fatty acid 
uptake defect in Mtb. The majority of the 20 most highly-expressed genes in 
the ΔlucA::hyg during infection in macrophages map to the mce1 locus. Up-
regulation of genes encoding the Mce1 fatty acid transporter in the ΔlucA::hyg 
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mutant during infection likely reflects an attempt by the bacterium to 
compensate for the absence of fatty acids that normally fuels Mtb’s 
metabolism. The mechanism that controls expression of the mce1 locus in 
response to fatty acid depletion is unknown but we hypothesize that Mtb has 
an ability to sense metabolite pools to control synthesis of the Mce1 fatty acid 
transporter complex.  
The Mtb cell envelope constitutes a formidable barrier to the transport 
of any hydrophobic molecule. Actinomycetal bacteria with mycolic acid-
containing cell walls that are capable of metabolizing cholesterol use the Mce4 
complex to import the sterol (Mohn et al., 2008; Pandey & Sassetti, 2008; 
Perkowski et al., 2016) and this has led to the idea that all four of the Mce 
complexes transport hydrophobic molecules across the Mtb cell wall. Various 
studies have linked Mce1 to Mtb virulence (Shimono et al., 2003; Gioffre et al., 
2005; Joshi et al., 2006) but the function of the Mce1 complex was hitherto 
unknown. It has been reported that inactivating Mce1 in Mtb induces a lipid 
homeostasis defect and the accumulation of free mycolic acids in the Mtb cell 
wall (Cantrell et al., 2013; Forrellad et al., 2014). Based on these observations 
it was hypothesized that the Mce1 may transport fatty acids and/or mycolic 
acids across the cell wall/membrane of Mtb but it was reported that Mce1 
mutant in Mtb displayed a minor defect in fatty acid uptake (Forrellad et al., 
2014). We used assays comparable to those previously described and 
detected major perturbations in fatty acid assimilation in our Mce1 mutants. 
We cannot fully explain the discrepancy between these findings but we have 
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noticed that spontaneous mutants of Mtb unable to produce phthiocerol 
dimycocerosate (PDIM) assimilate less fatty acids compared to PDIM positive 
strains. Our work was conducted in a PDIM positive strain of Mtb Erdman and 
we think this has allowed us to detect Mce1-mediated fatty acid transport.  
Studies with Mycobacterium leprae (Mlep) are consistent with the 
interpretation that Mce1 functions as a mycobacterial fatty acid transporter. 
The Mlep genome contains a single mce locus which is most similar to the 
mce1 operon found in Mtb and Mlep is fully capable of importing and 
metabolizing palmitate when the bacteria are recovered from animal tissues 
(Franzblau, 1988). The Mlep genome also encodes a homolog of lucA 
(ml2337) suggesting that LucA could be central for Mce1 function in this 
bacterium. Given that the Mlep genome does not conserve genes that encode 
proteins for cholesterol import/metabolism and this bacterium does not 
metabolize cholesterol, (Marques et al., 2015) it is likely that ml2337 has one 
role in Mlep. The finding that LucA facilitates fatty acid uptake and stabilizes 
components of the Mce1 transporter provides additional evidence that Mce1 
functions as a fatty acid transporter. Therefore the fatty acid uptake defect in 
the ΔlucA::hyg mutant is most likely a consequence of the degradation of 
Mce1 components.  
The mce1-4 loci make up four separate operons in the Mtb genome and 
each operon encodes the putative protein subunits that likely comprise the 
individual substrate-specific Mce transporters. Although Mce1 and Mce4 are 
likely the main transporters of fatty acids and cholesterol, respectively, we can 
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detect a residual level of fatty acid and cholesterol uptake and metabolism in 
mutants lacking individual loci. It is very likely that compensatory systems 
function to import these lipids in the absence of Mce1 and Mce4 and we are 
currently testing this hypothesis. 
Based on homology it is predicted that Mce operons encode 3 types of 
transporter subunits with discrete roles: i) two putative permease subunits 
(YrbE), ii) six cell wall associated proteins (Mce), and iii) two accessory/ mce 
associated membrane proteins (Mam). Function of the latter is the most 
elusive. The matter is also complicated by the presence of homologous mce 
associated proteins scattered throughout the Mtb genome. Recently it was 
reported that one such orphaned Mce associated protein Rv0199/OmamA 
facilitates cholesterol utilization in Msm and stabilizes the Mce1 complex in 
Mtb (Perkowski et al., 2016). This work demonstrates that LucA interacts with 
the Mce1 and Mce4 accessory subunits Rv0199/OmamA, Rv0177/Mam1C 
and Rv3492/Mam4A. And similarly to Rv0199/OmamA, we found that LucA is 
also required to stabilize subunits of the Mce1 transporter. Based on this we 
predict that LucA is recruited to the Mce1 and Mce4 complexes to stabilize or 
assemble the transporters via interactions with the accessory subunits. Given 
that MceG is required for cholesterol uptake and is thought to facilitate the 
import of additional nutrients in Mtb (Garcia-Fernandez et al., 2017; Joshi et 
al., 2006; Pandey & Sassetti, 2008) our finding that the MceG protein is also 
destabilized in the ΔlucA::hyg mutant may explain the various nutrient uptake 
defects in this mutant. Homology searches based on 3-dimensional structures 
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identified a putative protease inhibitor domain within the N-terminus of LucA 
(Kelley et al., 2015). We hypothesize that LucA may locally inactivate a 
protease to maintain the integrity of the transporter complexes. Regulating 
activity of the transport complexes through proteolysis could be a mechanism 
to rapidly halt nutrient uptake through the Mce transporters, however such a 
suggestion will require more research. 
During growth in the presence of cholesterol, Mtb shunts cholesterol-
derived methylmalonyl-CoA (originating from propionyl-CoA) towards the 
increased synthesis of methyl-branched, cell wall polyketide lipids (Griffin et 
al., 2012; Jain et al., 2007; Yang et al., 2009). This metabolic shunting 
requires that sufficient fatty acid derived acyl-AMP primers are available to 
support biosynthesis of polyketide lipids (Quadri, 2014). When excess fatty 
acids are supplied to infected macrophages, Mtb can enhance the flux of 
propionyl-CoA into polyketide lipids such as PDIM during infection (Lee et al., 
2013). It would be advantageous for Mtb to regulate fatty acid assimilation to 
maintain the acyl-AMP pools required for efficient synthesis of methyl-
branched lipids. Thus, coordination of cholesterol and fatty acid uptake by 
LucA could ensure that balanced levels of these nutrients are maintained for 
optimized metabolism.  
The central carbon and lipid metabolic pathways of Mtb have emerged 
as potential drug targets (Rhee et al., 2011; VanderVen et al., 2015), therefore 
understanding the bottlenecks or weaknesses in these pathways will assist TB 
drug discovery. Additionally, the flux of fatty acids into TAG and central 
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metabolism contributes to drug tolerance in Mtb (Baek et al., 2011), a 
phenotype that is further enhanced by immune pressure during in vivo 
infection (Liu et al., 2016). Targeting the specialized lipid metabolic pathways 
in Mtb that are involved in fatty acid and cholesterol utilization could be a 
viable strategy for the development of new drugs that reduce Mtb drug 
tolerance and augment current TB drug regimens. Our data have defined new 
participants in the complex processes of fatty acid and cholesterol assimilation 
by Mtb. A better understanding of the functional integration of Mtb’s 
specialized metabolic pathways is required to acquire a fuller appreciation of 
Mtb pathogenesis.  
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CHAPTER 3 
 
Insights into mechanisms of inter-regulation of cholesterol 
and fatty acid transport in Mycobacterium tuberculosis 
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Abstract 
M. tuberculosis has evolved to utilize fatty acids and cholesterol as the 
main carbon sources during infection, both at the level of the host cell and at 
the level of granuloma. Mtb requires strict regulation of metabolism of these 
carbon sources to maintain balance between supplying energy for survival and 
synthesis of lipids essential for virulence. Here we sought to identify the main 
mechanisms that the pathogen employs to balance import of fatty acids and 
cholesterol. We found that on one hand, catabolites of cholesterol negatively 
regulated the fatty acid transporter Mce1 at the transcriptional level. 
Conversely, long-chain fatty acids induced increased uptake of cholesterol. 
Additionally, we demonstrated that stability of the Mce1 transporter, and 
therefore fatty acid uptake was regulated at the protein level through 
protection from degradation by Zn2+ metalloprotease Zmp1. This protection 
was dependent on the Mce accessory subunit OmamA. While deletion of 
OmamA had no effect on cholesterol import, inactivation of both OmamA and 
Zmp1 led to a significant decrease in the amount of cholesterol catabolized. 
Therefore, we conclude that Mtb possesses mechanisms of inter-regulation of 
cholesterol and fatty acid assimilation, both at transcriptional and at protein 
levels through precise activity of specific proteases. 
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Introduction 
Mtb can persist within its host for decades, therefore acquisition of 
nutrients available within the host is crucial to survival of the pathogen. Mtb is 
uniquely adapted to metabolize fatty acids and cholesterol (Russell et al., 
2010; Lovewell et al., 2016), and most likely these processes are strictly 
regulated. Both of these lipids are degraded in Mtb with subsequent 
incorporation of catabolites into the TCA cycle to provide energy for bacterial 
survival. Metabolism of fatty acids and cholesterol rely on the same enzyme 
isocitrate lyase (Icl1) that performs dual function. It is an enzyme of the 
glyoxylate shunt that is used by Mtb during energy generation from fatty acids, 
and also functions in methylcitrate cycle that converts cholesterol breakdown 
products into succinate and pyruvate for incorporation into the TCA cycle 
(McKinney et al., 2000; Muñoz-Elías et al., 2006). Both fatty acids and 
cholesterol are required for synthesis of important virulence factors, such as 
phthiocerol dimycocerosates (PDIM), and various trehalose esters (sulfolipid-1 
and polyacyltrehaloses) (Rainwater & Kolattukudy, 1982; Cox et al., 1999; 
Beatty et al., 2000; Jain et al., 2007; Kaur et al., 2009; Lee, et al., 2013). 
Additionally, excess of fatty acids can be esterified and stored within Mtb in the 
form of triacylglycerol (TAG) (Daniel et al., 2011). Induction of TAG synthesis 
is also triggered by stress conditions, suggesting that this pathway may be 
used to reduce bacterial growth by diverting fatty acids from the TCA cycle 
(Baek et al., 2011). Therefore, maintaining a balance of fatty acids and 
cholesterol within the bacterial cell would be crucial for mycobacterial growth 
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and adaptation to survival within the host. Here we sought to identify 
mechanisms employed by Mtb to regulate uptake of these lipids. 
Mtb imports fatty acids through the Mce1 transporter, and cholesterol 
through the Mce4 transporter, which are encoded by the separate mce1 and 
mce4 loci in the Mtb genome. These complexes are comprised of two 
permease subunits (YrbE’s), six cell wall associated Mce proteins, and 
accessory subunits (Mam). 
Function of YrbE and Mce proteins in nutrient transport is predicted 
based on their homology, however the roles of accessory subunits Mam 
remain elusive. Mtb contains 5 additional homologues of the accessory 
proteins, encoded by genes scattered throughout its genome. Recently, it was 
shown that one of such Mce accessory proteins, OmamA, facilitates 
cholesterol utilization in Msm and stabilizes the Mce1 complex in Mtb 
(Perkowski et al., 2016). In the previous chapter we showed that LucA 
interacts with a number of accessory proteins (including orphaned OmamA 
and Mce4-associated Mam4B), and that LucA is required for stability of the 
Mce1 complex. Here we investigated further if these accessory proteins are 
involved in fatty acid and cholesterol uptake/metabolism. We determined that 
OmamA and Mam4B are required for certain steps in lipid import, and that 
they support transport of fatty acids and cholesterol, respectively. Moreover, 
we showed that inability to assimilate fatty acids in the absence of OmamA is 
achieved through activity of Zn2+ metalloprotease Zmp1. Targeted degradation 
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of specific transporters could serve as a rapid way to switch from intake of one 
nutrient to another in Mtb. 
Finally, we investigated inter-regulation of lipid transport at the 
transcriptional level. Although downregulation of transcription of the mce1 
operon was shown during macrophage infection (Casali et al., 2006), the 
impact of lipid substrates on the control of transcription of this operon has not 
been studied. We found that cholesterol catabolites downregulate expression 
of mce1 genes, representing another link between uptake of cholesterol and 
fatty acids.  
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Materials and Methods 
Bacteria and growth conditions 
M. tuberculosis strains were routinely grown at 37°C in 7H9 (broth) or 
7H11 (agar) media supplemented with OAD enrichment (oleate-albumin-
dextrose-NaCl), 0.05% glycerol and 0.05% tyloxapol (broth). AD enrichment 
consisted of fatty acid free albumin-dextrose-NaCl. Cholesterol (final 
concentration 100μM) and various fatty acids (final concentration 177μM) were 
added to the liquid media as tyloxapol:ethanol micelles as described (Lee et 
al., 2013). Propionate chloride and acetate chloride were added as water 
solution along with empty tyloxapol:ethanol micelles. Hygromycin 100 μg/ml, 
kanamycin 25 μg/ml, streptomycin 50 μg/ml, and apramycin 50 μg/ml were 
used for selection. For E. coli selection hygromycin was used at 150 μg/ml. 
Strain construction 
Mutant strains of Mtb were generated by allelic exchange (Mann et al., 
2011) with hygromycin resistance cassette mutant. Allelic exchange was 
confirmed by sequencing. Strains used in the study are shown in Table 3.1. 
qPCR 
Mtb was cultured at an initial OD600 of 0.1 in 7H9 AD medium in vented 
standing T-75 tissue culture flasks. After 5 days, cultures were normalized to 
OD600 of 0.7 in 5-8ml using spent medium, and 1,000X stock of lipid was 
added for 3h. Compounds at concentration of 10X IC50 were spiked in where 
indicated for 1 hour prior to addition of the lipid. The RNA was extracted and 
analyzed as previously described (Abramovitch et al., 2011). Housekeeping 
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gene sigA (rv2703) encoding sigma factor was used to normalize each 
sample. 
Table 3.1. Strains used in the study 
 
Transcriptional profiling 
Bacteria were cultured as described for qPCR. Bacterial RNA was 
isolated, amplified, dye labeled, and hybridized to the microarray as described 
(Rohde et al., 2007; Liu et al., 2016). 
Lipid uptake assays 
Mtb cultures were pre-grown in 7H9 AD for 5 days. Then, the cultures 
were normalized to OD600 of 0.7 in 8ml using spent medium, and 1,000X stock 
of lipid was spiked in for 3 hours (where indicated). In case of itaconic acid 
treatment, bacteria were pre-incubated with 2mM of this Icl1 inhibitor 1 hour 
prior to lipid addition. Then 0.2 μCi of radiolabeled substrate ([4-14C]-
cholesterol, [14C(U)]-palmitate, or [1-14C]-oleate) was added to bacteria. 1.5 ml 
Strain Location of hygromycin resistance cassette insertion Background
ΔlucA ::hyg  (283-469 bp) of rv3723  M. tuberculosis  Erdman
Δmam4B ::hyg  (1-483 bp) of rv3492c  M. tuberculosis  Erdman
ΔomamA ::hyg  (1-660 bp) of rv0199 M. tuberculosis  Erdman
Δzmp1 -omamA ::hyg  (starting at 1bp) of rv0198c  - (ending at 660 bp) of rv0199 M. tuberculosis  Erdman
Strain Genetic features Background
wild type  pMV306 smyc' ::mCherry M. tuberculosis  Erdman
ΔlucA ::hyg comp  pMV306 hsp60' ::rv3723  and smyc' ::mCherry ΔlucA ::hyg
Δmam4B ::hyg Comp  pMV306 hsp60' ::rv3493c-rv3492c Δmam4B ::hyg
ΔomamA ::hyg Comp  pMV306 hsp60' ::rv0199 ΔomamA ::hyg
wild type
(CDC1551, prpD reporter)
 pDEA (hygromycin resistance) + prpD' ::GFP + smyc'::mCherry M. tuberculosis CDC1551
Tn::cyp125
(CDC1551, prpD reporter)
Mycomar tranposon insertion in rv3545c
(kanamycin resistance)
wild type
(CDC1551, prpD reporter)
Tn::rv3542c
(CDC1551, prpD reporter)
Mycomar tranposon insertion in rv3542c
(kanamycin resistance)
wild type
(CDC1551, prpD reporter)
Tn::ltp2
(CDC1551, prpD reporter)
Mycomar tranposon insertion in rv3540c
(kanamycin resistance)
wild type
(CDC1551, prpD reporter)
Tn::ltp2  Comp
(CDC1551, prpD reporter)
 pVV16 + aacC4 (apramycin resistance) + hsp60' ::ltp2
Tn::ltp2
(CDC1551, prpD reporter)
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cultures were collected by centrifugation after 5, 30, 60 and 120 min of 
incubation at 37°C. Each bacterial pellet was washed thrice in 1 ml of ice-cold 
wash buffer (0.1% Fatty acid free-BSA and 0.1% Triton X-100 in PBS) and 
fixed in 0.2 ml of 4% PFA for 1h. The total amount of radioactive label 
associated with the fixed pellet was quantified by scintillation counting. The 
radioactive signal was normalized to the relative levels of bacterial growth, i.e. 
to the OD600 of the bacterial cultures before addition of radioactive label. The 
uptake rate was calculated by applying linear regression to the normalized 
radioactive counts over time, and uptake efficiency was expressed as a ratio 
of uptake rate for each strain/treatment relative to the wild type control/no 
treatment. 
Radiorespirometry assays 
Lipid oxidation was monitored by quantifying the release of 14CO2 from 
[4-14C]-cholesterol, and [1-14C]-oleate by radiorespirometry. Mtb cultures were 
pre-grown in 7H9 AD for 5 days. Then they were incubated at OD600 of 0.7 in 
5 ml 7H9 AD spent medium supplemented with 1.0 μCi of radiolabeled 
substrates in vented standing T-25 tissue culture flasks placed in a sealed air-
tight vessel with an open vial containing 0.5 ml 1.0 M NaOH at 37°C. After 5 
hours, the NaOH vial was recovered, neutralized with 0.5 ml 1.0 M HCl, and 
the amount of base soluble Na2
14CO3 was quantified by scintillation counting. 
The radioactive signal was normalized to OD600. % CO2 release was 
expressed as a ratio of normalized radioactive signal for each strain relative to 
the wild type control.  
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Results 
3.1. Cholesterol catabolites regulate transcription of the mce1 locus. 
Cholesterol downregulates transcription of the mce1 locus. 
In the previous chapter we provided evidence that the Mce1 complex 
functions as a fatty acid transporter. Although the expression profile of mce1 
genes has been studied during the different stages of growth in the regular 
axenic culture (Kumar et al., 2003), the potential impact of lipid substrates on 
the transcription of these genes was not investigated. 
To address this question, we analyzed the transcriptional response of 
wild type and ∆lucA::hyg mutant strains to a mixture of oleate and cholesterol 
by qPCR. We used the ∆lucA::hyg mutant as a comparator because of its 
known defect in transport of these lipids. Relative to wild type and 
complemented strains, the ∆lucA::hyg mutant had upregulated levels of mce1 
genes during macrophage infection (Figure 2.2). Since it is believed that 
macrophages provide both fatty acids and cholesterol to Mtb, it was not 
surprising that addition of both of these lipids to axenic culture led to a similar 
phenotype (Figure 3.1. A). 
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Figure 3.1. Cholesterol negatively regulates expression of the mce1 
operon in wild type Mtb. A qPCR quantification of RNA transcripts from 
indicated bacterial strains pre-grown in 7H9 AD media for 5 days (left), and 
then incubated with addition of oleic acid (OA) and cholesterol (right) for 3 
hours. Fold change was determined by normalizing to the wild type transcript 
levels. Data are means ± SD (n = 6). B Transcriptional response quantified by 
qPCR in wild type, ∆lucA::hyg mutant and complemented strains to addition of 
oleic acid and cholesterol. Fold change was determined for each strain by 
normalizing to the transcript levels before addition of the lipids. Data are 
means ± SD (n = 6). C Transcriptional response of mce1 operon in wild type 
Mtb to resting (left) and activated (right) macrophage infection. Data are 
adapted from (Schnappinger et al., 2003). D Transcriptional response to 
addition of cholesterol quantified by microarray in wild type Mtb. Fold change 
was determined by normalizing to the transcript levels before addition of 
cholesterol. Data are means (n = 3). 
*p < 0.05, **p < 5x10-5, ***p < 1x10-6, ****p < 0.01 (Student’s t test). 
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When we looked at the transcriptional response of mce1 genes to 
cholesterol and oleate for individual strains, we found that the wild type and 
complemented strains downregulated mce1, while the ∆lucA::hyg mutant was 
less efficient in this downregulation, consistent with the inability of this strain to 
import these lipids (Figure 3.1. B). Published data indicate that mce1 genes 
are downregulated in wild type Mtb at least during early stages of macrophage 
infection (Figure 3.1. C) (Schnappinger et al., 2003; Casali, et al., 2006; 
Homolka, et al., 2010) mimicking response to cholesterol and fatty acids 
(Figure 3.1. A). 
Next we tested if cholesterol alone can impact mce1 expression. 
Microarray analysis revealed that all genes in the mce1 locus were 
downregulated (up to 6.5 fold) in response to cholesterol (Figure 3.1. D). 
These results indicate that cholesterol can modulate expression of the Mce1 
fatty acid transporter. 
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Early catabolites of cholesterol downregulate transcription of the mce1 
locus. 
We proceeded to identify cholesterol catabolites responsible for 
regulation of the mce1 operon. Catabolism of cholesterol in Mtb is an 
elaborate process that involves breakdown of the i) side chain, ii) A and B 
rings, and iii) C and D rings (Figure 3.2). The first two steps can happen 
concurrently (Capyk et al., 2011), but the third one does not begin until the 
second is complete (Casabon et al., 2013; Wipperman et al., 2014). Early 
metabolites are known to regulate expression of the core cholesterol 
metabolism enzymes in the KstR regulon through direct binding to KstR 
repressor (Figure 3.2). We hypothesized that these early metabolites could 
also regulate mce1 expression. To test this hypothesis we analyzed 
transcription of mce1 genes (mce1A, mce1D, mce1E) in response to 
cholesterol in transposon mutants defective in early steps of cholesterol 
catabolism, i.e. side chain breakdown: Tn::cyp125, Tn::rv3542c and Tn::ltp2 
(Figure 3.3. A). Cyp125 is a cholest-4-en-3-one 26-monooxygenase, and it 
catalyzes the very first reaction of side chain metabolism: oxidation to the 
carboxylic acid. Although exact function of Rv3542c and Ltp2 is not yet 
assigned, they are believed to be involved in the subsequent steps of the side 
chain breakdown, which produce one acetate and two propionate molecules 
(Figure 3.2). 
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The Tn::cyp125 mutant did not downregulate mce1 genes in response 
to cholesterol (Figure 3.3. A), which demonstrates that the cholesterol 
metabolite(s) responsible for mce1 regulation is/are not produced in this 
mutant. Both Tn::rv3542c and Tn::ltp2 mutants downregulated mce1 genes to 
the same extent as the wild type strain. These results indicate that the mce1-
regulating molecule is produced downstream of Cyp125 but upstream of 
Rv3542c and Ltp2. Overexpression of Ltp2 in Tn::ltp2 mutant (Tn::ltp2 Comp) 
significantly abolished downregulation of mce1, demonstrating that Ltp2 
catalyzes reaction that diminishes amounts of the mce1-regulating cholesterol 
metabolite, which is likely to be the cholesterol side chain CoA thioester. 
Although propionate and acetate are also produced as the result of cholesterol 
side chain catabolism, only the cholesterol side chain CoA thioester would be 
used by Ltp2 as a substrate, and not these short chain fatty acids. These 
results indicate that early cholesterol metabolites such as side chain CoA 
thioesters are likely candidates in the regulation of the mce1 gene expression. 
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Figure 3.3. Cholesterol metabolites regulate expression of the mce1 
genes. A qPCR quantification of RNA transcripts from indicated bacterial 
strains pre-grown in 7H9 AD media for 5 days, and then incubated with 
addition of cholesterol, 100μM for 3 hours. Transcriptional response to 
cholesterol (fold change) was determined for each strain by normalizing to the 
transcript levels before addition of cholesterol. Data are means ± SEM (n = 4). 
B qPCR quantification of RNA transcripts from wild type Mtb pre-grown in 7H9 
AD media for 5 days, and then incubated with addition of indicated carbon 
sources for 3 hours. Compounds (inhibitors of cholesterol catabolism blocking 
release of propionate) were added where indicated 1 hour prior to carbon 
sources. Fold change was determined by normalizing to the transcript levels 
before addition of compounds or carbon sources. Data are means ± SEM (n = 
4). 
*p < 0.05, **p < 0.005 (Student’s t test). 
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Cholesterol breakdown product propionate downregulates transcription 
of the mce1 locus. 
We showed that a cholesterol side chain CoA thioester but not 
propionate is most likely responsible for downregulation of mce1 in Tn::ltp2 
mutant. However Tn::ltp2 mutant produced only 1 molecule of propionyl-CoA 
from the side chain, which is substantially lower than the total amount that wild 
type bacteria experiences if cholesterol metabolism goes to completion. 
Breakdown of 1 molecule of cholesterol releases 3-5 molecules of propionate: 
2 – from the side chain, 1 – from the A and B rings, and up to 2 - from the C 
and D rings (predicted). To test if propionate derived from cholesterol affects 
mce1 transcription, we analyzed mce1 expression in response to cholesterol 
when inhibitors of propionate release were added (Figure 3.3. B). These 
compounds were identified in Dr. VanderVen laboratory to block production of 
propionate from catabolism of both cholesterol side chain and rings (data not 
shown). Without cholesterol these propionate release inhibitors did not change 
mce1 transcription. However, they did partially abolish mce1 downregulation in 
response to cholesterol, suggesting importance of propionate in mce1 
transcription regulation. In support of this, propionate amounts comparable to 
the ones produced as the result of full cholesterol breakdown, downregulated 
mce1 as efficiently as cholesterol (Figure 3.3. B). Acetate had no effect on 
mce1 expression. Based on these results we conclude that the cholesterol 
breakdown product propionate downregulates mce1 transcription.  
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3.2. Long chain fatty acids induce an increase in cholesterol uptake by 
Mtb. 
Given that cholesterol metabolites regulate expression of mce1 genes 
encoding a fatty acid transporter, we sought to determine if cholesterol can 
affect fatty acid uptake. We quantified uptake of [1-14C]-oleic acid and [U-14C]-
palmitic acid by Mtb pre-incubated with cholesterol for 3 hours. Uptake of fatty 
acids decreased only by ~20% (Figure 3.4. A). This indicates that despite 
downregulation of mce1 gene expression, Mtb still imports fatty acids, either 
by using Mce1 that was produced prior to cholesterol addition or by using a 
different fatty acid transporter. Surprisingly, when we tested if there is a 
reverse correlation between cholesterol and fatty acid uptake, we found that 
oleic acid induced a significant increase in [4-14C]-cholesterol uptake (Figure 
3.4. A). 
Fatty acids undergo β-oxidation to release acetyl-CoA that is fed into 
the TCA and glyoxylate cycles. To distinguish if fatty acid itself or its 
metabolites impact cholesterol import, we used a known inhibitor of isocitrate 
lyase (icl1) – itaconic acid (Eoh & Rhee, 2014). Itaconic acid did not affect 
cholesterol uptake (Figure 3.4. B). Additionally, acetate did not induce an 
increase in cholesterol uptake. It is important to point out that for acetate we 
used a 9X molar concentration of oleic acid, considering that 1 mole of oleic 
acid produces 9 moles of acetate. Our results indicate that the signal for 
cholesterol import is mediated directly by intact fatty acid. 
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Finally, we wanted to evaluate the structural characteristics of fatty 
acids that enabled them to regulate cholesterol uptake. For saturated even 
chain fatty acid, we used palmitate (C16:0); for saturated odd chain fatty acid - 
margaric acid (C17:0); and for unsaturated even chain fatty acid - oleate 
(C18:1). All of the fatty acids tested induced a comparable increase in 
cholesterol uptake (Figure 3.4. C), indicating that saturation and 
evenness/oddness of fatty acid length are not determining factors in this 
process. 
Overall we can conclude that long chain fatty acids induce an increase 
in cholesterol uptake. 
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Figure 3.4. Fatty acids induce an increase in cholesterol uptake in Mtb. A 
Uptake of [4-14C]-cholesterol (chol), [1-14C]-oleic acid (OA), or [U-14C]-palmitic 
acid (PA) by wild type Mtb in 7H9 AD 3 hours after addition of indicated lipid 
(oleic acid, or cholesterol). B Uptake of [4-14C]-cholesterol by wild type Mtb in 
7H9 AD pre-incubated with or without itaconic acid 3 hours after addition of 
indicated lipid (oleic acid, or acetate). C Uptake of [4-14C]-cholesterol by wild 
type Mtb in 7H9 AD 3 hours after addition of indicated fatty acid (FA) (palmitic 
acid (C16:0), margaric acid (C17:0), or oleic acid (C18:1)). 
Data are means ± SD (n ≥ 2). 
*p < 0.05, **p < 0.01, ***p < 0.005 (Student’s t test). 
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3.3. Mce accessory proteins are essential for lipid import in Mtb, likely 
through protection from activity of specialized proteases. 
Our results indicate that despite the ability of cholesterol to 
downregulate expression of mce1, which encodes a fatty acid transporter, 
uptake of fatty acids was not significantly affected by cholesterol. Alternatively, 
fatty acids modulate cholesterol uptake, but transcription of the cholesterol 
transporter-encoding mce4 was not affected (data not shown). These 
observations led us to believe that regulation of transporters being used by 
Mtb might happen post-transcriptionally, even post-translationally. Such 
hypothesis was supported by the role LucA played in providing stability to 
subunits of the Mce1 and Mce4 transporters (Chapter 2). Therefore, we 
performed additional experiments to identify possible mechanisms regulating 
activity of transporters through their stability. 
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Mam4B facilitates internalization of cholesterol but not its binding to the 
bacterial surface. 
We showed in a previous chapter that LucA interacts with Mce1 and 
Mce4-accessory proteins Rv3492c/Mam4B, Rv0177/Mam1C, and 
Rv0199/OmamA. Perkowski and colleagues reported that deletion of 
Rv0199/OmamA leads to a marginal defect in cholesterol uptake in Msm 
(Perkowski et al., 2016), but the role of these accessory proteins in lipid 
assimilation in Mtb is unknown. To test if Mce4-associated Rv3492c/Mam4B is 
required for cholesterol import, we inactivated this protein by allelic exchange 
(Δmam4B::hyg) and quantified the rate of [4-14C]-cholesterol uptake in this 
mutant. We found that relative to the wild type and complemented strains the 
Δmam4B::hyg mutant is still capable of importing [4-14C]-cholesterol (Figure 
3.5. A). Importantly, the Δmam4B::hyg mutant has an obvious cholesterol 
metabolism defect resulting in an ~80% reduction in the mutant’s ability to 
metabolize [4-14C]-cholesterol (Figure 3.5. B). The phenotype of the 
Δmam4B::hyg strain is specific to cholesterol given that the mutant has no 
defect in the uptake or metabolism of [1-14C]-oleate (Figure 3.5. C,D). Our 
interpretation of these observations is that the Rv3492c/Mam4B mutant binds 
and/or partly imports cholesterol across the Mtb cell envelope which accounts 
for the uptake activity that we detect with this strain. Given that cholesterol is 
likely not metabolized by Mtb until the substrate reaches the bacterial cytosol, 
we predict that the final translocation of cholesterol across the bacterial 
cytoplasmic membrane is defective in the Δmam4B::hyg mutant and a 
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blockade at this step prevents subsequent degradation of cholesterol in this 
strain. Together these data indicate that Rv3492c/Mam4B is required to 
complete the process of Mce4-mediated cholesterol internalization by Mtb. 
 
 
 
Figure 3.5. Deletion of the Mam4B leads to cholesterol metabolism defect 
but does not affect cholesterol uptake. A and B Cholesterol import and 
metabolism by the Δmam4B::hyg mutant. Data are means ± SD (n = 4). C and 
D Oleate import and metabolism by the Δmam4B::hyg mutant. Data are 
means ± SD (n = 4). 
*p < 0.0001 (Student’s t test). 
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OmamA facilitates import of fatty acids. 
Next we decided to determine the role in lipid assimilation for another 
Mce accessory protein that interacted with LucA, Rv0199/OmamA. We 
inactivated Rv0199/OmamA by allelic exchange (ΔomamA::hyg) and 
quantified the [1-14C]-oleate uptake rate and metabolism levels in this mutant. 
We found that relative to the wild type and complemented strains, the 
ΔomamA::hyg mutant decreased [1-14C]-oleate import by ~65%, and 
metabolism by ~85% (Figure 3.6. A,B). The ΔomamA::hyg mutant had no 
significant defect in [4-14C]-cholesterol uptake or metabolism indicating that 
Rv0199/OmamA is involved solely in the uptake of fatty acids (Figure 3.6. 
C,D). Our results demonstrate that OmamA facilitates both initial binding and 
downstream translocation of oleic acid. This is in contrast to Mam4B, which is 
required only for the internalization step. We conclude that despite sharing 
homology, Mce associated proteins perform distinct functions in Mtb, both in 
terms of substrate specificity, and in terms of steps of import they support. 
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Figure 3.6. Deletion of Zmp1 reverses lipid uptake/metabolism in 
∆omamA::hyg. A and B Oleate import and metabolism by the ΔomamA::hyg 
and Δzmp1-omamA::hyg mutants. Data are means ± SD (n ≥ 4). C and D 
Cholesterol import and metabolism by the ΔomamA::hyg and Δzmp1-
omamA::hyg mutants. Data are means ± SD (n ≥ 4). 
*p < 0.001, **p < 0.002, ***p < 0.0001 (Student’s t test).   
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Deletion of Zmp1/Rv0198c restores fatty acid uptake in ∆omamA::hyg. 
Deletion of Rv0199/OmamA leads to degradation of the putative 
subunits of the Mce1 complex (Mce1A, Mce1D, Mce1E) despite no change in 
their transcript levels (Perkowski et al., 2016). Given that Rv0199/OmamA is 
required for uptake of fatty acids and that Mce1 is a fatty acid transporter, we 
can attribute inability of ∆omamA::hyg to import fatty acids to degradation of 
Mce1 transporter. But we still do not understand the exact function of 
accessory proteins in this process. There are three possible roles that 
accessory proteins might play: 
1) They are involved in transport and assembly of the Mce protein 
complex; 
2) They provide support to the complex to maintain its integrity; 
3) They protect the Mce complex from protease activity (jointly with 
LucA). 
To distinguish the third possibility from the rest, we decided to inactivate 
the protease that we suspected was responsible for the degradation of the 
Mce complex in the absence of an accessory protein. If accessory proteins are 
involved in protection from protease degradation, inactivation of this enzyme 
has the potential to rescue lipid uptake in the mutant lacking an accessory 
protein. 
To test this hypothesis we focused our attention on the protease 
encoded by rv0198c/zmp1, adjacent to rv0199/omamA. Zmp1 is a Zn2+ 
metalloprotease that was shown to be involved in modulation of phagosome 
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maturation and IL-1β processing in macrophages (Master et al., 2008; Ferraris 
et al., 2011; Petrera et al., 2012). We inactivated both Rv0198c/Zmp1 and 
Rv0199/OmamA by allelic exchange (Δzmp1-omamA::hyg), and measured 
uptake and metabolism of [1-14C]-oleate. Uptake and metabolism of oleic acid 
was restored in the Δzmp1-omamA::hyg mutant to ~70-80% of the wild type 
(Figure 3.6. A,B). These results indicate that the defect in fatty acid 
metabolism in the ΔomamA::hyg mutant resulted from active degradation by 
the specific protease, Zmp1. If OmamA was involved in transport/assembly of 
the Mce1 complex or in maintaining integrity of the Mce1 through stabilization 
of subunit complexes, then inactivation of Zmp1 would not restore uptake, 
since the transporter would still be nonfunctional. We have preliminary data 
showing that stability of Mce1 subunits (Mce1A, Mce1D, Mce1E) is restored in 
the Δzmp1-omamA::hyg mutant (data not shown), in support of the proposed 
role of OmamA as protector from Zmp1 protease activity. 
Similarly to the ΔomamA::hyg mutant, uptake of [4-14C]-cholesterol was 
not affected in the Δzmp1-omamA::hyg mutant (Figure 3.6. C). However, we 
detected a ~55% reduction in the Δzmp1-omamA::hyg mutant’s ability to 
metabolize [4-14C]-cholesterol relative to the wild type and ΔomamA::hyg 
mutant (Figure 3.6. D). Although we cannot fully explain these results, it is 
possible that specific proteases (Zmp1) function in combination with accessory 
proteins (OmamA) to regulate the balance in uptake of these essential lipids in 
Mtb. 
  
120 
Discussion 
While there is a body of evidence suggesting co-regulation of 
cholesterol and fatty acid metabolism in Mtb, data on the mechanisms that link 
uptake of these lipids are absent. Our current data provides evidence that 
these lipid substrates can cross-regulate their uptake by modulation of 
transporter transcription and stability.  
We found that intermediates of early cholesterol catabolism (likely 
cholesterol side chain CoA thioesters) downregulate expression of mce1 
genes, encoding a fatty acid transporter complex Mce1. Propionyl-CoA that is 
produced when cholesterol is fully catabolized also negatively regulates these 
genes. We speculate that early cholesterol metabolites modulate mce1 
expression as soon as cholesterol is inside of the bacterial cell, however as 
metabolism proceeds, propionyl-CoA may also assume this function. We 
believe that cholesterol might serve as a signal molecule for the lipid-rich 
environment experienced within the host cell. Downregulation of mce1 could 
be used to reduce fatty acid transporter activity to avoid overloading of the 
bacterial cell with fatty acids, which could have a knock-on effect on bacterial 
replication and drug tolerance (Garton et al., 2008; Baek et al., 2011; Daniel et 
al., 2011; Caire-Brändli et al., 2014; Rodríguez et al., 2014). Alternatively, 
downregulation of mce1 could coincide with a switch to an unknown 
alternative transporter to balance fatty acids/cholesterol levels. 
The mce1 operon is transcribed as a 13 gene polycistronic RNA, and it 
is preceded by rv0165c/mce1R, which encodes a transcription factor 
homologous to the fatty acid metabolism regulating repressor FadR of the 
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GntR family. In E coli binding of a long-chain fatty acid (>14 carbons) CoA 
thioester to FadR leads to its de-repression (Fujita et al., 2007). In Mtb Mce1R 
functions as a repressor of the mce1 operon (Casali et al., 2006), however its 
effectors are unknown. Our findings indicate that cholesterol metabolites 
modulate function of this operon, suggesting that they could serve as ligands 
for Mce1R. It is also possible that other transcription factors capable of binding 
cholesterol metabolites are involved in regulation of mce1 (Zeng et al., 2012). 
While significant changes in mce1 transcription were observed, only a 
slight decrease in fatty acid uptake was caused by cholesterol. However, fatty 
acids increased cholesterol uptake greatly (3-4 fold) within just 3-5 hours, 
despite negligible changes in mce4 transcription. By inhibiting protein 
synthesis (Chapter 2), we demonstrated that subunits of Mce transporters are 
stable in wild type Mtb (Figure 2.9. B), therefore effect of mce transcription 
shutdown on uptake of lipids most likely is delayed. Transport activity can be 
regulated through the activity of proteases, such as the Zn2+ metalloprotease 
Zmp1, to specifically degrade undesirable transport complexes. Function of 
the Zmp1 protease is dependent on the orphaned Mce accessory protein 
OmamA. Given the key role of LucA in preserving subunits of Mce 
transporters, we conclude that LucA interacts with accessory proteins to 
protect Mce transporters from degradation (Figure 3.7). 
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Figure 3.7. Proposed model for fatty acid and cholesterol uptake co-
regulation in Mtb. Cholesterol metabolites inhibit transcription of mce1 
operon. Fatty acids induce cholesterol uptake. Specific proteases (purple) are 
used to rapidly degrade unwanted transporters. Activity of these proteases is 
blocked by LucA and accessory Mam proteins.  
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Defect in cholesterol metabolism in the mutant lacking both OmamA 
and Zmp1 suggests the significant role of such proteases in maintaining 
balance in fatty acid and cholesterol import. In support of the idea that 
regulation of the lipid import is important for Mtb’s pathogenesis, Zmp1 was 
shown to be required for Mtb infection of macrophages and for survival in mice 
(Master et al., 2008).  
Finally, we found that certain accessory subunits of Mce1 and Mce4 
transporters are specific to their substrates, i.e. Mam4B – for cholesterol, and 
OmamA  – for fatty acids. More importantly, these accessory subunits regulate 
different steps of lipid import. These studies allowed us to determine that 
transport of cholesterol consists of at least two dissociable events: substrate 
binding/shuttling across the cell wall followed by the final translocation through 
the cytoplasmic membrane delivering cholesterol into the cytosol. The 
accessory subunit of Mce4 likely participates in the final translocation of 
cholesterol across the cytoplasmic membrane, while orphaned accessory 
protein OmamA appears to be involved in the binding/shuttling of fatty acids 
across the Mtb cell envelope. 
Overall our data demonstrate that fatty acids and cholesterol inter-
regulate import of each other. Metabolites of both of these lipids (acyl-AMP for 
fatty acids, and propionyl-CoA derived methylmalonyl-CoA for cholesterol) 
serve as required precursors for synthesis of sulfolipids and PDIM, methyl-
branched virulence lipids of Mtb (Jain et al., 2007; Singh et al., 2009; Yang et 
al., 2009; Griffin et al., 2012; Quadri, 2014). These anabolic pathways are 
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essential for adaptation of the pathogen to the intracellular environment, where 
fatty acids derived from macrophages relieve toxicity caused by cholesterol 
derived propionyl-CoA metabolites (Lee et al., 2013). Regulation of a balance 
in intracellular levels of cholesterol and fatty acids would ensure optimal 
metabolism and therefore survival of Mtb during infection. Here we have 
begun to unravel the mechanisms of this co-regulation. Deeper knowledge of 
inner-workings of balanced lipid assimilation in Mtb will expand our 
understanding on how Mtb adapts to the host environment. 
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CHAPTER 4 
 
Identification of genes required for fatty acid assimilation by 
Mycobacterium tuberculosis during macrophage infection 
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Abstract 
M. tuberculosis acquires fatty acids and cholesterol from its host during 
infection. Although assimilation of cholesterol was studied extensively, yet the 
machinery required for fatty acid intake by mycobacteria has remained 
enigmatic. In the Chapters 2 and 3 we demonstrated that Mce1 is a fatty acid 
transporter, and examined regulation of this protein complex. However genetic 
requirements for assimilation of fatty acids during infection have not yet been 
studied in an unbiased manner, mostly because the experimental approaches 
required to address this question had not been developed. Here we describe a 
novel unbiased approach using fluorescent substrates for the metabolic 
labeling of a transposon mutant library during macrophage infection. Mutants 
defective in accumulation of the fluorescent label are sorted and sequenced 
prior to further characterization of their phenotype through their ability to 
metabolize lipids in axenic culture. This approach allowed us to isolate 
mutants unable to assimilate fatty acids in both macrophages and in axenic 
culture, as well as mutants that were only defective within the host cell 
environment. This screen identified a number of proteins, including Mce1 
subunits and MceG that are essential for fatty acid uptake by Mtb inside of the 
host. 
  
132 
Introduction 
It is believed that one of the key nutrients utilized by Mtb within the host 
is fatty acids. 
First, this pathogen has access to this lipid. Mtb infection results in 
induction of a foamy phenotype in macrophages (Almeida et al., 2012; Singh 
et al., 2012), the hallmark of which is accumulation of lipid bodies most likely 
comprised of triacylglycerols and cholesterol esters. Mtb can acquire fatty 
acids directly from the macrophage (Lee et al., 2013) or as products of 
triacylglycerol breakdown (Daniel et al., 2011). Mycobacteria-containing 
vacuoles can be found fused with these lipid bodies as revealed by electron 
microscopy, suggesting lipid bodies as a possible route of fatty acid delivery to 
the pathogen (Peyron et al., 2008; Podinovskaia et al., 2013; Caire-Brändli et 
al., 2014). In the lungs, Mtb resides in foamy macrophages of granulomas 
(Hunter et al., 2007; Cáceres et al., 2009) or in the midst of lipids in caseating 
granulomas (Kim et al., 2010), all of which comprise an excellent source of 
fatty acids. Importantly, Mtb isolated from mouse lungs had higher preference 
for metabolism of fatty acids compared to bacteria grown in axenic culture, 
indicating a metabolic shift towards fatty acids in Mtb in vivo (Segal & Bloch, 
1956). 
Second, Mtb upregulates fatty acid β-oxidation and fatty acid 
metabolism-related genes in the macrophage, in a mouse model of infection, 
and in human lung tissue (Schnappinger et al., 2003; Rachman et al., 2006; 
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Rohde et al., 2007; Fontán et al., 2008; Tailleux et al., 2008; Homolka et al., 
2010; Rohde et al., 2012). 
Despite all these data supporting utilization of fatty acids by Mtb during 
infection, very little is known on how Mtb actually imports and degrades fatty 
acids. As the genome of Mtb is highly enriched for genes predicted to be 
devoted to β-oxidation (~100) (Cole et al., 1998), assigning of their function 
absent direct demonstration of phenotype, is problematic. Only recently we 
started to gain information on specific details relating to enzymes of this 
pathway (Taylor et al., 2010; Venkatesan & Wierenga, 2013; Srivastava et al., 
2015). We described Mce1 as a fatty acid transporter for the first time, and it 
has been shown that inactivation of Mce1 leads to defect in bacterial growth in 
mouse infection (Joshi et al., 2006). Here we sought to identify genes involved 
in the complex processes associated with the uptake and downstream 
assimilation of carbon from lipid substrates in context of the host. 
We developed a forward genetic screen to identify Mtb mutants 
defective in assimilation of fatty acids during macrophage infection. We 
metabolically labeled macrophages infected with transposon mutants using 
fluorescently-tagged palmitate, and flow-sorted bacterial mutants unable to 
acquire this fatty acid from macrophage. We subsequently analyzed selected 
mutants for their ability to metabolize fatty acids and cholesterol in axenic 
culture. This unbiased approach allowed us to identify genes encoding the 
fatty acid transporter Mce1, Mce accessory subunit OmamB, ATPase MceG, 
134 
GTP pyrophosphokinase RelA, Rv2799 and Rv0966c to be required for 
assimilation of fatty acids inside of the host. 
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Materials and Methods 
Bacteria and growth conditions 
M. tuberculosis strains were routinely grown at 37°C in 7H9 (broth) or 
7H11 (agar) media supplemented with OAD enrichment (oleate-albumin-
dextrose-NaCl), 0.05% glycerol and 0.05% tyloxapol (broth). AD enrichment 
consisted of fatty acid free albumin-dextrose-NaCl. Hygromycin 100 μg/ml, 
kanamycin 25 μg/ml, and streptomycin 50 μg/ml were used for selection. For 
E. coli selection hygromycin was used at 150 μg/ml. 
Strain construction and transposon screen 
Generation of wild type and ∆lucA::hyg strains constitutively expressing 
mCherry is described in Chapter 2. 
Transposon HiMar (kanR) mutant library (~2X104 independent mutants) 
was generated as described (Lee et al., 2013) in a wild type Mtb Erdman with 
integrated plasmid pDEA43n smyc'::mCherry (hygR). Sorting was performed 
as described below. Sorted material was plated onto 7H11 OAD agar. Pooled 
mutants were frozen in 15% glycerol and re-grown in 7H9 OAD before re-
infection. Individual mutants were recovered in culture. Chromosomal DNA 
was isolated and the transposon insertion sites were PCR amplified and 
sequenced according to (Prod’hom et al., 1998).  
Macrophage isolation and culturing 
Macrophages were differentiated using bone marrow cells from BALB/c 
mice (Jackson Laboratories, USA) and maintained in DMEM supplemented 
with 10% heat inactivated fetal calf serum, 2.0 mM L-glutamine, 1.0 mM 
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sodium pyruvate, 10% L-cell-conditioned media and antibiotics (100 U/ml 
penicillin and 100 mg/ml streptomycin) at 37°C and 7.0% CO2 for 10 days 
before infection. Media without antibiotics was used for infections with Mtb. 
Flow cytometry and sorting. 
Bacteria (Tn mutant library or selected strains) were pre-grown in 7H9 
OAD media till mid log phase. Murine bone marrow-derived macrophages 
were seeded into T-75 tissue culture flasks (2x107 cells per flask) and infected 
with Mtb at a MOI of 4:1. 4 flasks were infected with Tn mutant library for the 
screens. Where indicated, 7958 compound was added at concentration of 
10μM at the time of infection and left in media for 3 days. After 3 days of 
infection Bodipy-palmitate (final concentration 9 μM) conjugated to de-fatted 
1% BSA was added to the cells for 1 hour pulse and then chased with cell 
media for another hour. The infected macrophages were scraped into 15 ml of 
homogenization buffer (250 mM sucrose, 0.5 mM EGTA, 20 mM HEPES, 
0.05% gelatin, pH 7.0) and pelleted by centrifugation at 514xG (1,500 rpm, 
Beckman Allegra 6KR centrifuge, GH-3.8 rotor), followed by cell lysis by 70 
passages through a 25 gauge needle. 5 ml of cell lysate was centrifuged at 
146xG (800 rpm) for 10 minutes, supernatant (suspensions of phagosomes) 
was retained and treated with 0.1% Tween-80 at 4°C for 15 minutes to break-
open Mtb containing vacuoles. Isolated bacteria were washed twice in 
PBS+0.05% tyloxapol, and then in PBS+0.1% Triton X-100+0.1% fatty acid-
free BSA. Bacterial suspensions were resuspended in PBS+0.05% tyloxapol 
and passed through a 25 gauge needle 20 times. Aliquots of these 
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suspensions were diluted in Basal uptake buffer (Nazarova & Russell, 2017) 
for flow cytometry analysis or sorting performed on S3TM sorter (Bio-Rad). 
Data were analyzed using FlowJo (Tree Star, Inc). 
Imaging of intracellular lipid inclusions 
Confluent monolayers of macrophages in Ibidi eight-well glass-bottom 
chambers were infected with bacteria at a MOI of 4:1. Extracellular bacteria 
were removed after 4 hours of infection. Where indicated, 7958 compound 
was added at concentration of 10μM at this time and left in media for 3 days. 
Infected macrophages were maintained in cell culture medium at 37°C and 7% 
CO2 for 3 days. For metabolic labeling Bodipy-palmitate (final concentration 20 
μM) conjugated to 1.0% de-fatted bovine serum albumin (BSA) was pulsed for 
30 minutes and chased for a 1-2 hour with fresh media. Live-cell images were 
acquired as described (Podinovskaia et al., 2013). Post-acquisition, images 
were analyzed using Volocity (PerkinElmer Life Sciences).  
Lipid uptake assays 
Mtb was cultured at an initial OD600 of 0.1 in 7H9 AD medium in vented 
standing T-75 tissue culture flasks. After 5 days, cultures were normalized to 
OD600 of 0.7 in 8ml using spent medium, and 0.2 μCi of radiolabeled 
substrates ([4-14C]-cholesterol, [14C(U)]-palmitate, or [1-14C]-oleate) was added 
to bacteria. After 5, 30, 60 and 120 min of incubation at 37°C 1.5 ml of the 
bacterial cultures were collected by centrifugation. Each bacterial pellet was 
washed thrice in 1 ml of ice-cold wash buffer (0.1% Fatty acid free-BSA and 
0.1% Triton X-100 in PBS) and fixed in 0.2 ml of 4% PFA for 1h. The total 
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amount of radioactive label associated with the fixed pellet was quantified by 
scintillation counting. The radioactive signal was normalized to the relative 
levels of bacterial growth, i.e. to the OD600 of the bacterial cultures before 
addition of radioactive label. The uptake rate was calculated by applying linear 
regression to the normalized radioactive counts over time, and uptake 
efficiency was expressed as a ratio of uptake rate for each strain relative to the 
wild type control. 
Radiorespirometry assays 
Mtb cultures were pre-grown in 7H9 AD for 5 days. Then they were 
incubated at OD600 of 0.7 in 5 ml 7H9 AD spent medium supplemented with 
1.0 μCi of radiolabeled substrates ([4-14C]-cholesterol, [14C(U)]-palmitate, or 
[1-14C]-oleate) in vented standing T-25 tissue culture flasks placed in a sealed 
air-tight vessel with an open vial containing 0.5 ml 1.0 M NaOH at 37°C. After 
5 hours, the NaOH vial was recovered, neutralized with 0.5 ml 1.0 M HCl, and 
the amount of base soluble Na2
14CO3 was quantified by scintillation counting. 
The radioactive signal was normalized to the relative levels of bacterial growth 
by determining the OD600 for the bacterial cultures. % CO2 release was 
expressed as a ratio of normalized radioactive signal for each strain relative to 
the wild type control. 
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Results 
Validation of the proposed genetic screen 
To determine which genes are required for Mtb to accumulate fatty 
acids during macrophage infection, we exploited metabolic labeling with 
fluorescent Bodipy-palmitate as described in Chapter 2. We have shown that 
the ∆lucA::hyg mutant has a significant defect in importation of fatty acids 
during macrophage infection. To find mutations that would generate defects 
similar to the ∆lucA::hyg, we infected macrophages with a transposon mutant 
library constitutively expressing mCherry for three days, pulse labeled with 
Bodipy-palmitate, isolated bacteria, and sorted mutants with low Bodipy 
fluorescence. 
To validate our experimental platform we infected two sets of 
macrophages, one with wild type Mtb and another one with the ∆lucA::hyg 
mutant, both constitutively expressing mCherry and analyzed them after 
metabolic labeling and isolation. We gated on the mCherry-positive singlet 
bacterial population (Figure 4.1. A and B). As expected, the ∆lucA::hyg mutant 
had a lower level of Bodipy signal than the wild type strain (Figure 4.1. C). 
Then we combined these two populations at the ratio of 1:1, and flow-sorted 
bacteria with low Bodipy signal (Figure 4.1. D). The gates for sorting were 
drawn so that there would be minimum “contamination” by wild type bacteria 
(based on Figure 4.1. C). The sorted bacterial population demonstrated ~90% 
purity (Figure 4.1. E). Equal aliquots of the sorted population were grown on 
plates with or without hygromycin. The ∆lucA::hyg mutant is hygromycin-
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resistant while the wild type strain is not, which allows us to quantify the 
specificity of the sort. 98.68% of the colonies were hygromycin-resistant, i.e 
represented the ∆lucA::hyg mutant population. These results demonstrate that 
the experimental protocol for sorting bacteria unable to take up fluorescent 
fatty acids during macrophage infection has validity. 
 
 
Figure 4.1. Bacterial populations with low Bodipy-palmitate uptake 
during macrophage infection can be sorted out with high level of purity. 
Bacteria were isolated from macrophages on the third day of infection after 
pulse-labeling with Bodipy-palmitate. A Flow cytometry analysis of mock 
bacterial isolate from uninfected macrophages. B Gating strategy for sorting 
out mCherry-positive bacterial population. C Flow cytometry analysis of 
Bodipy-palmitate incorporation by wild type and ∆lucA::hyg mutant isolated 
from pulse labeled macrophages. D Flow cytometry of combined wild type and 
∆lucA::hyg mutant (1:1) used for sorting of population with low Bodipy-
palmitate signal. E Purity of sorted low Bodipy-palmitate population.  
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Two rounds of genetic screen to identify mutants deficient in uptake of 
fatty acids during macrophage infection 
To perform the genetic screen we used a transposon mutant library 
generated in the wild type Erdman strain, constitutively expressing mCherry 
from an integrated plasmid. Additionally, we isolated wild type and the 
∆lucA::hyg mutant from labeled macrophages to determine the gate for sorting 
out bacteria with low Bodipy-palmitate signal (Figure 4.2. A). 105 clones were 
sorted out and plated, however, only ~1.28X104 gave rise to colonies. 9 
randomly selected clones were tested by microscopy to assess the exhibited 
defect in uptake of Bodipy-palmitate during macrophage infection. One clone 
with a transposon insertion in the cpsA gene was strongly negative (Table 4.1, 
Figure 4.2. C), and this phenotype was also verified by flow cytometry (Figure 
4.2. B). CpsA (capsular polysaccharide biosynthesis) belongs to LytR-CpsA-
Psr family of proteins that play an important role in bacterial cell wall/capsule 
synthesis. In Mycobacterium marinum CpsA participates in cell wall assembly, 
and inactivation of CpsA leads to a decrease in the content of mycobacterial 
cell wall polysaccharide arabinogalactan (Wang et al., 2015). CpsA and Lcp1, 
another member of this protein family are required for ligation of 
arabinogalactan to peptidoglycan in Mtb (Grzegorzewicz et al., 2016; Harrison 
et al., 2016). Therefore, we concluded that inability to take up fatty acids by 
this mutant during macrophage infection is most likely caused by perturbed 
integrity of the mycobacterial cell wall and is not directly linked to the fatty acid 
uptake machinery or its regulation. 
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In support of these observations with randomly selected mutants, we 
found that pooled sorted material were heterogeneous with respect to Bodipy-
palmitate uptake (Figure 4.2. C), suggesting that only a fraction of this 
population had a specific defect in fatty acid uptake during macrophage 
infection. Thus, we decided to perform the second round of mutant selection 
(Figure 4.2. D). We again used wild type and ∆lucA::hyg mutant strains as 
controls for drawing the sorting gate. We also compared mutants pooled in the 
first round with the original input mutant library, and noted an enrichment for 
mutants with low Bodipy-palmitate signal (Figure 4.2. D). From the second 
round of enrichment, we collected 105 clones, and ~5.3X104 of them were able 
to grow on the agar plates. We noted a significant decrease in the Bodipy-
palmitate signal with each step of the sort, indicating increasing purity of the 
sorted pools (Figure 4.3). 
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Figure 4.2. Two rounds of genetic screen to identify mutants deficient in 
uptake of fatty acids during macrophage infection. A Left, Flow cytometry 
of Bodipy-palmitate incorporation by wild type and ∆lucA::hyg mutant isolated 
from pulse labeled macrophages. These data were used to determine the gate 
for the sorting. Right, Flow cytometry of transposon mutant library for sorting of 
population with low Bodipy-palmitate signal. B Flow cytometry analysis of 
Bodipy-palmitate incorporation by Tn::cpsA mutant isolated from the first round 
of screen. C Substantial fraction of mutants isolated in the 1st round of the 
screen is still capable of accumulating Bodipy-palmitate during macrophage 
infection. Bodipy-palmitate does not accumulate in Tn::cpsA mutant as 
cytosolic lipid inclusions. Representative confocal images of infected 
macrophages (red = mCherry Mtb, green = Bodipy-palmitate). Scale bar 5.0 
μm. D Left, Flow cytometry of Bodipy-palmitate incorporation by wild type and 
∆lucA::hyg mutant isolated from pulse labeled macrophages. These data were 
used to determine the gate for the second round of sorting. Middle, Flow 
cytometry of original unsorted transposon mutant library. Right, Flow 
cytometry of transposon mutant library isolated after first round of screen used 
for the second round of sorting of population with low Bodipy-palmitate signal. 
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Table 4.1. Randomly selected mutants from the first round of the screen 
tested for their ability to assimilate Bodipy-palmitate during macrophage 
infection 
Rv 
name 
Common 
name 
Description 
Number 
of 
mutants 
* 
Positive for 
Bodipy-
palmitate 
puncta 
rv1564c treX trehalose biosynthesis 1(1) Yes 
rv1829   Unknown 2(1) Yes 
rv1910c   Unknown 1(1) Yes 
rv2958c   
glycosyl transferase, required for 
resistance to killing by human 
macrophages 
1(1) Yes 
rv3045c adhC 
probable alcohol dehydrogenase, 
adjacent to fecB - import of Fe3+ 
1(1) Yes 
rv3329   
possibly in promoter of rv3330-
dacB1 - peptidoglycan synthesis 
1(1) Yes 
rv3484 cpsA 
bacterial cell wall/capsule 
synthesis; likely arabinogalactan 
and peptidoglycan assembly in 
mycobacteria 
2(1) No 
rv3573c fadE34 adjacent to kstR 1(1) Yes 
rv3865 espF ESX-1 1(1) Yes 
Highlighted in yellow – mutant negative for Bodipy-palmitate puncta 
* the number of independent insertions found in the specific gene is shown in parenthesis   
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Figure 4.3. Flow cytometry analysis of Bodipy-palmitate incorporation by 
original unsorted transposon mutant library, transposon mutants 
purified in the first round of screen, and transposon mutants purified in 
the second round of screen.   
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38 and 46 independent clones were sequenced from the first and the 
second rounds of selection, respectively. The first round library contained only 
one or two copies of the mutants with the transposon insertion in the same 
gene, while the second round had multiple copies (Table 4.2). This is another 
indication of increasing specificity of the mutants with subsequent rounds of 
selection. Some mutants that were found in the second round were absent 
from the first one (Table 4.3), which could be explained by low frequency of 
them in the first round. Most importantly, there were 7 mutants that were found 
in both rounds, suggesting that the selection process had specificity (Table 
4.4).  
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Table 4.2. Mutants identified in the first round of screen. 
Blue font denotes lipid metabolism-related genes. Red font denotes genes of 
potential interest. % of lipid assimilation are color coded based on their value, 
where 0% is red, and 100% is blue. * the number of independent insertions 
found in the specific gene is shown in parenthesis. 
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Table 4.3. Mutants identified in the second round of screen.  
Blue font denotes lipid metabolism-related genes. Red font denotes genes of 
potential interest. % of lipid assimilation are color coded based on their value, 
where 0% is red, and 100% is blue. * the number of independent insertions 
found in the specific gene is shown in parenthesis. 
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Characterization of lipid metabolism defect in selected mutants 
Although there was an obvious enrichment in mutants with low uptake 
of Bodipy-palmitate with each round of the screen, we still anticipated to find 
off-target or trivial mutants in each of the pools. To help reduce their number, 
we selected 38 mutants to test with microscopy (Figure 4.4). We compared 
amounts of bacteria with Bodipy puncta for each of the mutants to the wild 
type. We assigned 100% if the amount of bacteria with Bodipy puncta was 
equal to that of the wild type, and 0% if we couldn’t find a single bacterium with 
Bodipy-puncta. We estimated that 75% of the mutants identified only in the 
first round of the screen had over half of bacteria positive for Bodipy-palmitate 
(Table 4.2). For the second round there were 45% of such mutants (Table 
4.3), and only 15% - for the mutants identified in both rounds (Table 4.4). 
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Figure 4.4. Pulse labeling of transposon mutants with Bodipy-palmitate 
on third day of macrophage infection. Representative confocal images are 
shown (red = mCherry Mtb, green = Bodipy-palmitate). Scale bar 5.0 μm. 
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Figure 4.4. (Continued) 
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To quantify these observations we performed flow cytometry on 
selected mutants. We used treatment with the 7958 compound as the negative 
control, since it demonstrated the lowest amount of Bodipy-palmitate uptake 
compared to the wild type and the ∆lucA::hyg strains (Figure 4.5 A-B). This 
7958 compound is a recently described small molecule that inhibits Mtb 
growth in macrophages and in media containing cholesterol (Johnson et al., 
2017; VanderVen et al., 2015). 7958 also blocks uptake of fatty acids in Mtb 
when grown in axenic culture (Figure 4.5 C). We quantified mean Bodipy 
fluorescence for each of the 13 individual mutants tested and normalized it 
assigning 100% to no treatment and 0% to 7958 treatment (Figure 4.5 D). 
Mutants that demonstrated the strongest defect in assimilation of 
fluorescent fatty acid during macrophage infection can be split in four 
categories: 
1) The ones required for maintenance of cell wall integrity (cpsA, 
rv1339) 
2) The ones involved in regulation of metabolism during starvation 
(relA, ppdK). 
3) The ones linked to lipid uptake machinery (mceG, omamB, mce1D, 
mce4C) 
4) The ones with unknown link to lipid metabolism (rv0966c, rv3018c, 
rv2799). 
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Figure 4.5. Quantification of Bodipy-palmitate uptake by transposon 
mutants on third day of macrophage infection. A Flow cytometry analysis 
of Bodipy-palmitate incorporation by wild type, ∆lucA::hyg mutant, and wild 
type treated with 7958 compound isolated from pulse labeled macrophages. B 
Treatment with 7958 compound abolished Bodipy-palmitate uptake by wild 
type Mtb during macrophage infection. Representative confocal images are 
shown (red = mCherry Mtb, green = Bodipy-palmitate). Scale bar 5.0 μm. C 
Treatment with 7958 compound abolished [1-14C]-oleate uptake by wild type 
Mtb in axenic culture. D Flow cytometry quantification of Bodipy-palmitate 
incorporation by transposon mutants isolated from pulse labeled 
macrophages. Wild type was taken for 100%, and 7958 treatment for 0%. Tn 
presort – original transposon library used for the screen; Tn 1st round – pooled 
mutants identified after the first round of screen; Tn 2nd round – pooled 
mutants identified after the second round of screen. Pale blue bars – mutants 
only found in the first round; pale green bars – mutants only found in the 
second round; white bars – mutants identified in both rounds. 
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To further characterize the defect in fatty acid uptake in these mutants, 
we measured fatty acid metabolism in axenic culture by quantifying the 
catabolic release of 14C-CO2 from [1-
14C]-oleate (Table 4.2-4). This assay 
allowed us to identify mutants in which a fatty acid uptake defect is not 
triggered by macrophage environment (Figure 4.6. A). Mutants that had 
significant defect in fatty acid metabolism even in axenic culture either had 
transposon insertions in mce1 operon (mam1A and mce1D) or in genes 
encoding proteins possibly linked to it (omamB – accessory Mce protein, 
adjacent to omamA – accessory protein stabilizing Mce1 protein complex, 
mceG – shown to be linked to mce1 in epistasis study (Joshi et al., 2006)). 
The only exception from this rule was a mutation in rv0966c, encoding a 
protein of unknown function but adjacent to cspR – which encodes a copper 
sensitive operon repressor, which could possibly link copper sensing with fatty 
acid uptake. 
As we have shown earlier a link between cholesterol and fatty acid 
metabolism, we tested selected mutants with a fatty acid assimilation defect in 
macrophages (highlighted in two shades of red in Figure 4.6. A) for their ability 
to metabolize [4-14C]-cholesterol. We excluded Tn::cpsA mutants from this 
experiment, since its fatty acid intake defect was most likely caused by 
perturbed integrity of the mycobacterial cell wall. The only mutant impaired in 
cholesterol metabolism was found to be Tn::mceG (Figure 4.6. B). 
Overall, we can conclude that the defect of Tn::mce1D, Tn::omamB and 
Tn::rv0966c mutants in fatty acid acquisition during macrophage infection is 
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caused by an intrinsic inability to assimilate fatty acids, and the defect of 
Tn::mceG mutant – by inability to assimilate both fatty acids and cholesterol. 
Contrary, the fatty acid uptake defect in Tn::rv2799 and Tn::relA mutants is 
triggered by the macrophage environment (Figure 4.6. A). 
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Figure 4.6. Analysis of selected mutants for their ability to metabolize 
fatty acids and cholesterol. A Analysis of selected mutants based on their 
ability to import Bodipy-palmitate during macrophage infection (quantified by 
flow cytometry, X axis) and to metabolize [1-14C]-oleic acid in axenic culture (Y 
axis). Red shading (both light and dark) – mutants with defect in fatty acid 
assimilation during macrophage infection. Darker red shading – mutants 
defective in fatty acid assimilation in macrophages and in fatty acid 
metabolism in axenic culture. B Analysis of mutants (highlighted in two shades 
of red in panel A) based on their ability to metabolize [4-14C]-cholesterol (X 
axis) and [1-14C]-oleic acid (Y axis) in axenic culture. Yellow and orange 
shading – mutants with no substantial defect in cholesterol metabolism in 
axenic culture; where yellow – mutants with no defect, and orange – with 
defect in fatty acid metabolism in axenic culture. Purple shading – mutants 
defective in metabolism of both fatty acids and cholesterol in axenic culture. 
Tables 4.2-4.4 were used to create this figure. Pale blue dots – mutants only 
found in the first round; pale green dots – mutants only found in the second 
round; black dots – mutants identified in both rounds.  
163 
MceG is required for both fatty acid and cholesterol uptake. 
MceG is predicted to be an ATPase that functions in conjunction with 
both the Mce1 and Mce4 transporters (Joshi et al., 2006). Inactivation of mceG 
leads to a growth defect in media with cholesterol as a single carbon source, 
similar to mce4 inactivation. Additionally, MceG was shown to be required for 
cholesterol metabolism in Mtb (Pandey & Sassetti, 2008), and cholesterol 
uptake in Msm (García-Fernández et al., 2017), however the role of MceG in 
fatty acid assimilation had not been described previously. According to results 
of our screen, among all the mutants tested Tn::mceG demonstrated the 
strongest defect in fatty acid uptake during macrophage infection. Therefore 
we decided to test directly if MceG is required for uptake of fatty acids in 
axenic culture. In parallel with metabolism measurements, we quantified 
uptake efficiency for this mutant and compared it to the wild type strain. We 
detected ≥90% decrease in fatty acid uptake/metabolism, 75% decrease in 
cholesterol uptake, and 90% in cholesterol metabolism (Figure 4.7).  
Based on these results we conclude that MceG is required for import of 
both fatty acids and cholesterol. Mce4 is a known cholesterol transporter, and 
Mce1 was just revealed to be responsible for fatty acid transport. Consistent 
with genetic interaction of mceG with mce1 and mce4 loci (Joshi et al., 2006), 
our results support an idea that MceG functions as an ATPase providing 
energy for transport of these lipids via Mce1 and Mce4 transporters. 
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Figure 4.7. Tn::mceG mutant has a significant defect in uptake and 
metabolism of fatty acids and cholesterol. A and B Palmitate import and 
metabolism by the Tn::mceG mutant. C and D Oleate import and metabolism 
by the Tn::mceG mutant. E and F Cholesterol import and metabolism by the 
Tn::mceG mutant. 
Data are means ± SD (n = 4). *p < 0.0001 (Student’s t test)  
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Discussion 
While a substantial body of evidence suggests that Mtb relies on the 
utilization of fatty acids inside its host, the genetic requirements for this 
process remain largely uncharacterized. We used an unbiased genetic screen 
to identify some of the key players in this process.  
We employed metabolic labeling of a transposon mutant library during 
macrophage infection using fluorescently labeled fatty acid – Bodipy-palmitate. 
To assess if any fatty acid uptake defect is host-dependent we also quantified 
fatty acid metabolism of individual mutants in axenic culture. We found that 
Tn::mceG, Tn::mce1D, Tn::omamB and Tn::rv0966c are deficient in fatty acid 
assimilation regardless of their surroundings, while fatty acid uptake defect in 
Tn::rv2799 and Tn::relA mutants is triggered by the intra-macrophage 
environment.  
We show for the first time that MceG is required for fatty acid 
assimilation during macrophage infection and in axenic culture, which supports 
the proposed function for this protein as a putative ATPase providing energy 
for both Mce1 and Mce4 transporter function. Tn::mceG mutant was among 
the most abundant in our screen, and it had one of the strongest defects in 
lipid uptake and metabolism, supporting its essential role in these processes. 
We did determine earlier that Mce1 is a fatty acid transporter in Mtb, but 
we did not know if it performs this function inside of the host. Our results 
indicate that a subunit of Mce1 complex, Mce1D, is required for fatty acid 
transport in Mtb during macrophage infection. Another Mce-related protein 
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identified in our screen, OmamB, is an orphaned Mce accessory subunit 
encoded by a gene adjacent to omamA. OmamA is a Mce accessory subunit, 
required for protection of Mce1 from degradation by the protease Zmp1. It is 
highly likely that OmamB and OmamA are working jointly to stabilize Mce1, 
and therefore deletion of OmamB results in inactivation of fatty acid transport. 
We conclude that Mce1 is the main fatty acid transporter for Mtb at the early 
stage of macrophage infection. 
We found that Rv0966c, previously unlinked to lipid metabolism, is 
required for assimilation of fatty acids in Mtb both in macrophages and in 
axenic culture. The rv0966c is adjacent to cspR encoding a copper sensitive 
operon repressor, inferring a possible link between copper sensing and fatty 
acid uptake. Importance of this gene is supported by high expression of the 
locus including cspR and rv0966c in Mtb in the mouse infection model (Talaat 
et al., 2007). Interestingly, a locus containing putative fatty acid metabolism 
genes rv0971c-rv0975c is located adjacently downstream, and EchA7 
encoded by rv0971c is required for mouse infection (Ward et al., 2010). 
The Tn::rv2799 and Tn::relA mutants in which fatty acid uptake defect is 
only triggered by macrophage infection are also of an interest. Unfortunately 
there is not much known about rv2799 except that it is adjacent to rv2800 
encoding putative hydrolase. RelA mediates the stringent response to nutrient 
deprivation by regulating levels of (p)ppGpp (Avarbock et al., 1999). In Mtb it is 
required for long term survival in vitro and in vivo, however deletion of RelA 
has no effect on Mtb growth during short term macrophage infections (Primm 
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et al., 2000; Dahl et al., 2003; Klinkenberg et al., 2010; Weiss & Stallings, 
2013). Additionally, inactivation of RelA causes downregulation of mce1, mce3 
and mce4 loci in response to starvation (Dahl et al., 2003), indicating that RelA 
might be implicated in the control of lipid import. Interestingly, our data 
indicates that inactivation of RelA doubles fatty acid uptake in axenic culture. 
Obviously, more work needs to be done to determine if RelA regulates lipid 
transport in the hostile environment of a macrophage. 
This screen allowed us to identify numerous genes required for fatty 
acid acquisition by Mtb during macrophage infection, however, it did have 
some limitations. We had to validate the phenotype for each of the mutants 
individually, because of the false Bodipy-palmitate negative clones in our 
screened pools. This could be explained by the heterogeneous response of 
Mtb to macrophage infection, which is observed even in the wild type strain. 
Although we did recover a few mutants that likely had defects in their 
cell wall integrity, making them vulnerable to infection, we believe that the 
majority of clones with mutations in genes essential for infection were 
eliminated due to their inability to grow on the agar plates after recovery from 
macrophages. At the same time, it is possible that inactivation of lipid uptake 
might result in a severe survival defect for Mtb in macrophages, and we 
missed such mutants. To identify such essential genes, inducible mutants, 
where genes could be inactivated after bacteria have entered the host, could 
be used in the future. 
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This work is the first one addressing a long standing question of how 
Mtb assimilates fatty acids from the host. Identification of MceG and Mce1 in 
this screen indicates the prevalent role of these proteins in fatty acid import. It 
is of interest to learn which transport systems Mtb employs in different cell 
types, in cells with altered immune status, or at later stages of infection. We 
believe that the experimental platform developed here can be applied to 
answer these questions to further evaluate the role of fatty acids in Mtb 
infection in vivo. 
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CHAPTER 5 
 
Summary and further directions 
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Despite strong belief in the field that fatty acids are acquired and 
metabolized by Mtb inside of the host, little was known how fatty acid 
assimilation happens. Here we revealed a few key players in this process and 
possible mechanisms of its regulation. 
We have expanded our understanding of a role Mce transporters play in 
lipid transport and shed new light on their organization and regulation. The 
mce1-4 loci make up four separate operons in the Mtb genome and each 
operon encodes the putative protein subunits (2 permeases YrbEA and 
YrbEB, 6 Mce proteins and variable number of accessory subunits of unknown 
function) that likely comprise the individual Mce transporters. It is thought that 
each Mce transporter is substrate-specific: Mce4 designated to cholesterol 
import (Pandey & Sassetti, 2008) and Mce1 is described here to import fatty 
acids. Based on cholesterol assimilation studies with Mce4 accessory subunit 
Mam4B mutant, we propose that Mce4 imports cholesterol via a two-step 
process that involves cholesterol binding/shuttling across the cell wall followed 
by the final translocation through the cytoplasmic membrane delivering 
cholesterol into the cytosol (Figure 5.1). The permease subunits may 
participate in the final translocation of cholesterol across the cytoplasmic 
membrane while the Mce proteins likely participate in the binding/shuttling of 
cholesterol across the Mtb cell envelope. Although Mtb is considered a gram-
positive bacteria, its outer layer of lipids makes its cell wall more similar to that 
of gram-negative bacteria, and therefore binding/shuttling of lipids across the 
Mtb cell envelope may be analogous to what has been proposed for lipid 
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trafficking by Mce proteins across the periplasm of gram-negative bacteria 
(Malinverni & Silhavy, 2009; Thong et al., 2016; Nakayama & Zhang-Akiyama, 
2017). This two-step mechanism of nutrient uptake may be a generalizable 
mechanism for all Mce transporters. 
We found that the LucA protein is required for intake of both fatty acids 
and cholesterol, and inactivation of LucA leads to degradation of Mce1 
subunits and MceG, an ATPase predicted to supply energy for Mce 
transporters. Homology searches based on 3-dimensional structures identified 
a putative protease inhibitor domain within the N-terminus of LucA (Kelly et al., 
2015). We hypothesize that LucA may locally inactivate a protease to maintain 
the integrity of the transporter complexes. Based on our data showing 
interaction between LucA and accessory subunits of Mce1 and Mce4, we 
suggest that these accessory subunits recruit LucA to inhibit protease activity 
(Figure 5.1). This hypothesis is partially supported by degradation of Mce1 
proteins and subsequent defect in fatty acid uptake in the absence of OmamA. 
We verified that the Mce1 protein disappearance in OmamA mutant resulted 
from protease activity, by inactivation of Zn2+ metalloprotease Zmp1 in this 
mutant. This degradation of Mce subunits could be a mechanism to rapidly 
halt nutrient uptake through the specific Mce transporters and possibly switch 
to a different route of nutrient assimilation. 
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Figure 5.1. Model for Mce mediated transport of lipids in Mtb. The MceA-F 
proteins bind and shuttle nutrients across the outer lipid layer and “pseudo-
periplasmic space” of the Mtb cell wall (step 1). The cytoplasmic membrane 
permeases YrbE’s translocate nutrients across the membrane using energy 
provided by ATPase MceG (G) (step 2). The accessory subunits Mam’s likely 
act as adapters to recruit additional proteins to the complex such as LucA. 
Each transporter is specific for its lipid substrate, and coordination of their 
function is performed by LucA and accessory proteins Mam’s through 
protection from degradation by protease (P). In the absence of accessory 
proteins Mam’s or LucA protease degrades Mce and MceG proteins, rendering 
transporters nonfunctional. 
  
179 
We believe that these efficient means to regulate lipid import in Mtb 
should be investigated further. It is very likely that proteases other than Zmp1 
are involved in regulation of Mce function. To find proteases inhibited by LucA 
we propose to genetically screen for mutations that will restore lipid uptake in 
the ∆lucA::hyg mutant strain. Metabolic labeling with fluorescent fatty acids 
and prpD’::GFP reporter could be employed for such screen to distinguish 
proteases regulating fatty acid and cholesterol assimilation, respectively. 
Among other unanswered questions about Mce transporter organization are 
specificity of proteases towards specific Mce subunits (Mce, YrbE or MceG), 
and identification of interacting partners within Mce complexes. Besides Mce1 
and Mce4, Mtb likely uses alternative lipid transporters which still need to be 
identified. This prediction comes from observation of residual level of fatty acid 
and cholesterol uptake and metabolism in mutants lacking Mce1 and Mce4, 
respectively. Mce2 and Mce3 could be possible candidates, considering that 
their function has not been determined yet. 
As co-metabolism of fatty acids and cholesterol in Mtb is predicted (Lee 
et al., 2013), we have explored possible co-regulation of these lipids. We 
found that cholesterol metabolites downregulate transcription of the mce1 
locus, with no substantial effect on fatty acid uptake in the short term. These 
results suggest that posttranscriptional regulation is used by Mtb to rapidly 
respond to the changing environment. We also discovered that fatty acids 
induce higher levels of cholesterol uptake. We propose further investigation of 
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the mechanisms involved in this enhancement of cholesterol accumulation by 
performing a genetic screen with fluorescently-labeled cholesterol. 
Finally, we conducted a forward genetic screen to identify requirements 
for Mtb to assimilate fatty acids at an early stage of macrophage infection. We 
identified a group of proteins that are required for uptake of fatty acids both in 
macrophages and in axenic culture, as well as a group of proteins which 
function in fatty acid uptake is triggered only inside of the host cell. This work 
needs to be followed up with an in-depth investigation of roles played by these 
proteins. Interestingly, Mce1D, OmamB and MceG were found to be required 
for fatty acid assimilation in macrophage, reinforcing significance of the Mce1 
complex, Mce accessory subunits, and the ATPase MceG, despite high 
redundancy in lipid metabolism in Mtb. 
It is important to remember that the majority of the work described here 
was done in resting murine bone marrow-derived macrophages, which does 
not fully reflect all the nuances of in vivo infection. Inside of an infected 
individual, Mtb experiences a spectrum of immune responses associated with 
changes in available nutrients (Olive & Sassetti, 2016; Huang et al., 2017; 
Mishra et al., 2017). For example, cholesterol-responsive KstR regulon is 
equally expressed in Mtb during infection of both resting and activated 
macrophages (Schnappinger et al., 2003; Homolka et al., 2010). However, the 
ability to import cholesterol through Mce4 is required for survival of the 
pathogen only in activated macrophages or at the later stages of mouse 
infection when T cells produce IFN-γ to activate these immune cells (Joshi et 
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al., 2006; Pandey & Sassetti, 2008). These observations suggest that i) 
cholesterol is available to Mtb independently of the activation status of the host 
cell, however ii) nutrients that can be imported independently of Mce4 are 
used by Mtb for growth in resting macrophages. Importantly, Mce1 was shown 
to be required for Mtb survival in mice in the first two weeks of mouse infection 
(Sassetti & Rubin, 2003). Additionally, the LucA mutant with inactivated 
subunits of multiple Mce transporters demonstrates a growth defect in resting 
macrophages, supporting an idea that transporters other than Mce4 are used 
by Mtb in macrophage at this state. And since inactivation of LucA disables 
both fatty acid and cholesterol uptake, it is logical to conclude that fatty acids 
are being used by Mtb in resting macrophages. Therefore, metabolism of Mtb 
inside of the host is extremely dynamic: both in terms of nutrients and 
transporters used by Mtb. 
Identification of a full lipid importing apparatus is necessary to shed light 
on the importance of certain nutrients in cells of specific immune status. It 
would be also intriguing to determine which cells are more permissive for 
bacteria unable to import lipids. Using mutants with inducible inactivation of 
LucA, MceG or specific lipid transporters for mouse infection, with subsequent 
evaluation of bacterial distribution between immune cells of different types 
might help to answer this question. 
The central carbon and lipid metabolic pathways of Mtb have emerged 
as potential drug targets (Rhee et al., 2011; VanderVen et al., 2015), therefore 
understanding the bottlenecks or weaknesses in these pathways will assist TB 
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drug discovery. Additionally, the flux of fatty acids into TAG and central 
metabolism contributes to drug tolerance in Mtb (Baek et al., 2011), a 
phenotype that is further enhanced by immune pressure during in vivo 
infection (Liu et al., 2016). Targeting the specialized lipid metabolic pathways 
in Mtb that are involved in fatty acid and cholesterol utilization could be a 
viable strategy for the development of new drugs that reduce Mtb drug 
tolerance and augment current TB drug regimens. The data presented in this 
dissertation revealed previously unknown mechanisms of fatty acid and 
cholesterol assimilation by Mtb. A better understanding of the functional 
integration of Mtb’s specialized metabolic pathways is required to acquire a 
fuller appreciation of Mtb pathogenesis. 
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